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ABSTRACT 
 
Background:  Planning, implementing, monitoring, temporal evolution and prognosis differ 
between type 1 diabetes (T1DM) and type 2 diabetes (T2DM).  To date, few administrative 
diabetes registries have distinguished T1DM from T2DM, reflecting the lack of required 
differential information and possible recording bias.   
Objective:  Using a classification tree model, we developed a prediction rule to distinguish 
T1DM from T2DM accurately, using information from a large administrative database. 
Methods: The Medical Archival Retrieval System (MARS) at the University of Pittsburgh 
Medical Center from 1/1/2000-9/30/2009 included administrative and clinical data for 209,642 
unique diabetic patients aged ≥ 18 years.  We identified 10,004 T1DM and 156,712 T2DM 
patients as probable or possible cases, based on clinical criteria.  Classification tree models were 
fit using TIBCO Spotfire S+ 8.1 (TIBCO Software).  We used 10-fold cross-validation to choose 
model size.  We estimated sensitivity, specificity, positive predictive value (PPV), and negative 
predictive value (NPV) of T1DM. 
Results: The main predictors that distinguished T1DM from T2DM include age < 40 vs. ≥ 40 
years, ICD-9 codes of T1DM or T2DM diagnosis, oral hypoglycemic agent use, insulin use, and 
Roslyn A Stone, PhD 
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episode(s) of diabetic ketoacidosis diagnosis.  History of hypoglycemic coma, duration in the 
MARS database, in-patient diagnosis of diabetes, and number of complications (including 
myocardial infarction, coronary artery bypass graft, dialysis, neuropathy, retinopathy, and 
amputation) are ancillary predictors.  The tree-structured model to predict T1DM from probable 
cases yields sensitivity (99.63%), specificity (99.28%), PPV (89.87%) and NPV (99.71%). 
Conclusion: Our preliminary predictive rule to distinguish between T1DM and T2DM cases in a 
large administrative database appears to be promising and needs to be validated.  The public 
health significance is that being able to distinguish between these diabetes subtypes will allow 
future subtype-specific analyses of cost, morbidity, and mortality.  Future work will focus on 
ascertaining the validity and generalizability of our predictive rule, by conducting a review of 
medical charts (as an internal validation) and applying the rule to another MARS dataset or other 
administrative databases (as external validations). 
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1.0  INTRODUCTION 
Diabetes is one of the most costly and burdensome chronic diseases of our millennium. 
According to the latest World Health Organization report, more than 220 million people 
worldwide suffer from diabetes.1 In 2005, an estimated 1.1 million people died from diabetes.2  
This number will very likely double by 2030.1  As of 2007 in the United States, 23.6 million 
people (7.8% of the population) have diabetes 3 and total national associated costs with diabetes 
are exceeded $218 billion, including $174.4 billion for diagnosed diabetes, $18 billion for 
undiagnosed diabetes, $25 billion for pre-diabetes, and $636 million for gestational diabetes.4  
Diabetes and its complications represent a major burden and pose a major challenge to healthcare 
systems.   Therefore, public health prevention and intervention are urgently needed. 
An increasing amount of scientific literature is now available on producing accurate 
information from administrative data.  Advantages of use of administrative data to determine 
disease incidence include feasibility, accessibility and low cost. However, straightforward use of 
administrative data can produce biased information on cases of chronic disease like diabetes.  
Other challenges of using administrative data include representativeness of the population and 
multiple episodes of health services utilization by a single patient.  
There are four types of diabetes: Type 1 diabetes (T1DM), Type 2 diabetes (T2DM), 
gestational diabetes mellitus (GDM), and diabetes from other causes.   This thesis will focus on 
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T1DM and T2DM.  For outcomes evaluation, it is important to distinguish T1DM from T2DM.  
Planning, implementing, monitoring of appropriate interventions, temporal evolution, 
complications and prognosis differ between T1DM and T2DM.  Health care utilization and 
outcome also differ by types of diabetes.  Accurate information about the magnitude, 
distribution, and types of diabetes are needed in order to inform policy and support health care 
evaluation. Investigators in health services research often turn to the International Classification 
of Diseases (ICD) diagnosis codes in administrative records to study the effect of health care 
delivery on disease outcomes.  However, the ability of administrative records to distinguish 
T1DM and T2DM is limited due to the lack of required information, definitive diagnosis in 
clinical practice, and possible recording bias (e.g., coders enter a non-specific ICD code).5-6  A 
critical step in using administrative data to study T1DM and T2DM is to develop and validate 
methods to distinguish T1DM and T2DM accurately.    
Decision tree methods, also called recursive partitioning methods, are analytic strategies 
that were developed to classify or segment a target population for the purpose of clinical 
diagnosis and/or prognosis in public health.  Classification and regression trees (CART), one 
type of decision tree methodology, is nonparametric procedure developed by Brieman and 
colleagues.7   CART identifies easily defined, mutually exclusive population subgroups whose 
members share characteristics that are important predictors of the outcome of interest. CART can 
efficiently segment a population into meaningful subsets, which allows researchers to easily 
identify segments of a population that are more or less likely to exhibit the outcome.  Advantages 
of tree-based methods are that they do not require a parametrical specification of the relationship 
between the predictors and the outcome.  Additionally, assumptions of linearity that are made in 
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linear and logistic models are not required for tree-based methods.  A major strength is that tree-
based methods are adept at identifying important interactions between predictor variables. 
In this thesis, we used administrative data consisting of known T1DM and T2DM 
patients, including two sub-cohorts of probable and possible cases, from the Medical Archival 
Retrieval System (MARS) at the University of Pittsburgh Medical Center (UPMC) and built a 
tree-structured model to distinguish T1DM and T2DM cases using TIBCO Spotfire S+ 8.1 
(TIBCO Software).8  We used V-fold cross validation method to choose the model size.  
Distinguishing variables between T1DM and T2DM were obtained from the tree-based model, 
and sensitivity and specificity were estimated.   In the future, we aim to apply the preliminary 
predictive model to another MARS dataset, and conduct a review of medical charts as an internal 
validation.    This will ultimately lead to separate analyses on processes and outcomes of T1DM 
and T2DM cases.  
1.1 INTRODUCTION TO DIABETES MELLITUS 
The classification of diabetes includes four clinical classes: (1) T1DM results from β-cell 
destruction, leading to absolute insulin deficiency; (2) T2DM results from a progressive insulin 
secretory defect on the background of insulin resistance; (3) other specified types of diabetes due 
to other causes, e.g., genetic defects in β-cell function, genetic defects in insulin action, disease 
of the exocrine pancreas (such as cystic fibrosis), and drug- or chemical-induced (such as in the 
treatment of AIDS or after organ transplantation); (4) GDM is diabetes diagnosed during 
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pregnancy.  We do not consider GDM or other specified types of diabetes as diabetes cases in 
this thesis. 
1.2 POTENTIAL IDENTIFYING FACTORS BETWEEN TYPE 1 (T1DM) AND 
TYPE 2 DIABETES (T2DM) 
T2DM account for approximately 90% to 95% of prevalent diabetes, and T1DM about 5% to 
10%.  A step in understanding associations between T1DM and T2DM and disease outcomes is 
to develop methods to accurately identify individuals with T1DM or T2DM in administrative 
databases.  Potential differential characteristics or risk factors between T1DM and T2DM are 
summarized in [Table 1]. 
T1DM (previously known as insulin-dependent or childhood-onset diabetes) is 
characterized by a lack of insulin production.  In the United States, the annual incidence is 15 to 
18 cases per 100,000 of the childhood population.9  Males and females appear to be almost 
equally affected.10  There is no apparent correlation with socioeconomic status.  Data on age-
standardized incidence in relation to racial or ethnic background indicate a range of more than 35 
new cases annually per 100,000 population in Finland (45/100,000/year) and Sardinia 
(38.8/100,000/year) to less than 1 per 100,000 in China and parts of South America.9-11  In the 
United States, the occurrence of T1DM in blacks had previously been reported to be only 
between one-third and two thirds of that in whites.  More recent data suggest that the incidence 
of T1DM in African Americans may be as high as in White Americans.12  However, it is not 
clear this new increase in incidence among African Americans is exclusively T1DM or includes 
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cases of T2DM presenting in ketoacidosis and thus misclassified.  Peaks of presentation occur in 
two age groups: at 5 to 7 years of age and at the time of puberty.  The first peak corresponds to 
the time of increased exposure to infectious agents coincident with the beginning of school.  The 
latter corresponds to the pubertal growth spurt induced by increased pubertal growth hormone 
secretion and gonadal steroids that antagonize insulin action.  Emotional stresses that accompany 
puberty also have been implicated.  Most T1DM cases are younger than 20 years at diagnosis 
and present in diabetic ketoacidosis (DKA).13  Symptoms include excessive excretion of urine 
(polyuria), thirst (polydispsia), constant hunger, weight loss, vision change and fatigue.  
Ketoacidosis is responsible for the initial presentation of many (about 25 to 40%) diabetic 
children and likely to be present more often in children younger than 5 years of age.  Diabetic 
ketoacidosis exists when there is hyperglycemia (glucose 300 mg/dl), ketonemia (ketones 
strongly positive at greater than 1:2 dilution of serum), acidosis (pH 7.30 or less and bicarbonate 
15 mEq/L or less), glucosuria, and ketonuria in addition to the clinical features of tachypnea 
(Kussmaul respiration) and cerebral obtundation.10  These symptoms may occur suddenly.  
Measurement of C-peptide kinetics or of urinary excretion of C-peptide can be used as an index 
of endogenous insulin secretion.14  T1DM has long been known to have an increased prevalence 
among persons with such autoimmune disorders as Addision disease, celiac disease and 
Hashimoto thyroiditis.15  Evidence from T1DM prevention studies suggests that measurement of 
islet autoantibodies identifies individuals who are at risk for developing T1DM.16   T1DM is 
known to be associated with an increased frequency of certain histocompatibility loci antigens 
(HLAs), in particular, DR3 and DR4.  Although no presently available single marker or test can 
accurately predict T1DM, a combination of immune and genetic markers may provide 
predictability.17-18   Without daily administration of insulin, T1DM is rapidly fatal.  
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Recommended therapy for T1DM consists of the following components: (1) use of multiple dose 
insulin injections (3-4 injections per day of basal and prandial insulin) or continuous 
subcutaneous insulin infusion (CSII, or insulin pump therapy); (2) matching of prandial insulin 
to carbohydrate intake, pre-meal blood glucose, and anticipated activity; and (3) for many 
patients (especially if hypoglycemia is a problem), use of insulin analogs.10, 16  Another synthetic 
analogue of amylin, pramlintide, also is available as an injectable agent combined with insulin 
for treating T1DM. 
T2DM (formerly called non-insulin-dependent or adult-onset diabetes) results from the 
body’s ineffective use of insulin.  T2DM is largely the result of excess body weight and physical 
inactivity, which cause insulin resistance.  About 80 to 90% of persons with T2DM are 
overweight or have metabolic syndrome characteristics, but some who are leaner and more active 
do not have the metabolic syndrome.   Symptoms may be similar to those of T1DM, but are often 
less marked.  As a result, the disease may be diagnosed several years after onset, once 
complications have already arisen.   About one half of patients with newly diagnosed T2DM 
have established chronic complications.19  T2DM is more common in women, and in certain 
racial and ethnic groups including African Americans, Hispanics and Native Americans.19   
T2DM has been viewed as a disorder of aging, with an increasing prevalence with age.  This 
remains true today, even though a disturbing trend has become apparent in which T2DM in 
children is rising dramatically. 
 The classification of diabetes into its two most prominent types (T1DM and T2DM) 
seems straightforward in theory but in practice is increasingly confusing as more Americans 
become overweight.  Although T1DM patients are traditionally lean, many are now overweight 
and have metabolic syndrome characteristics.  C-peptide measurements are not very helpful for 
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those who are difficult to classify, but measuring three antibodies, including IA-2 (islet antigen 
512), anti-GAD65 (glutamic acid decarboxylase), and anti-insulin antibodies in high titers, can 
clarify a diagnosis of latent T1DM.  Younger age at onset, ideal or lean body habitus, severe loss 
of glycemic control with or without ketonemia, and weight loss all suggest insulin deficiency but 
might not be definitive.   ICD-9 codes with 250.x1 or 250.x3 seems to assign to the T1DM 
specifically, while 250.x0 or 250.x2 to T2DM or other unspecified diabetes.  However, ICD-9 
codes might not be accurately entered; therefore using ICD-9 codes to distinguish types of 
diabetes may be unreliable.  Currently, no methods are available to accurately distinguish types 
of diabetes in administrative data. 
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Table 1: Potential Differential Characteristics or Risk Factors of Type 1 and Type 2 Diabetes 
Potential Differential Characteristics or 
Risk factors 
Type 1 Diabetes (T1DM) Type 2 Diabetes (T2DM) 
Age of onset Mainly in childhood (5-7 years) or puberty Adult; pubertal in some children 
Onset Acute; Severe Mild-severe; often insidious 
Insulin secretion Deficiency Variation 
C-peptide can be used as an index of 
endogenous insulin secretion§  
(Normal value: fasting: 0.78-1.89 ng/mL or 
0.26-0.62 nmol/L) 
Decreasing or lack Normal or higher than normal 
Insulin sensitivity Normal Decreased or resistant 
Symptoms for diagnosis of diabetes* 
 
• Usually the symptoms (polyuria, polydipsia, 
polyphagia and weight loss) over a several-week 
period are common 
• Plasma glucose concentration usually in the range 
300 to 500 mg/dL. 
• A sodium value less than 120 mm/L is usually 
associated with severe hypertriglycemia that can lead 
to spurious hyponatremia. 
• The presentation of T2DM can be more subtle 
and sometimes clinical silent. 
Islet antigen /auto-antibodies / genetics • High titers of islet cell, GAD, IA2 
• Type 1A (immune-mediated): 90% with positive 
islet autoantibodies  
o Genetics: 30-50% DR3 and DR4 in 90% 
non-Hispanic white children 
o Genetics: 90% DR3 or DR4 in 50% black 
children 
o Genetics: <3% DQB1*0602 in Latin 
American children 
• Type 1B (other forms of diabetes with severe insulin 
deficiency): with negative islet autoantibodies 
Negative islet auto-antibodies;  with unknown 
genetics 
Insulin dependence Permanent Temporary; may occur later 
  
9 
 
Table 1 continued 
Potential Differential Characteristics or 
Risk factors 
Type 1 Diabetes (T1DM) Type 2 Diabetes (T2DM) 
Medication Mainly insulin therapy; may or may not combined with 
insulin analogs or amylin agonist 
Mainly single or combined OHA and/or combined 
with insulin or amylin agonist 
Association with obesity Most not  More likely to be overweight (BMI >25 kg/m2) 
Diabetic ketoacidosis (DKA): based on the 
blood pH (< 7.3), serum bicarbonate (< 10 
mg/dL or <15-18 mmol), and the presence 
of significant ketosis (ketonemia, 
ketouria), glucosuria.  In prolonged and 
severe cases, Kussmaul respiration is 
present (an odor of acetone on the 
breath). 
• 25-40 % of children with newly diagnosed T1DM 
present with DKA (children who are younger (less 
than 5 years), without a first-degree relative with 
T1DM, and from a family of lower socioeconomic 
status are at higher risk of DKA at onset of T1DM). 
• Majority of DKA episode occur in patients with 
established diabetes 
Occasionally develop: 
• May occur in hyperglycemic hyperosmolar state 
of T2DM 
• ¼ adolescents with T2DM have ketoacidosis at 
presentation. 
 
Hypoglycemic coma: mainly occurs in 
those being treated with insulin 
(differential diagnosis from hyperglycemic 
and ketoacidotic diabetec coma: 
hypoglycemic coma lacks of ketoacidotic 
hyperpnea or dehydration and can be 
improve by glucose injection) 
More common situation in patients with T1DM has 
injected too much insulin in relation to the amount of 
carbohydrates consumed, or has not reduced the insulin 
dose despite increase physical activity etc. 
Rarer among T2DM patients being treated with 
insulin alone or in combination with other medication 
Associated autoimmune Disease Most patients with Type 1A diabetes have one or more 
additional auto-immune disease.  The most common 
associated disorders are thyroid autoimmunity (Grave 
disease or Hashimoto’s thyroditis) or cliac disease or 
Addison disease. 
Not associated 
Environmental risk factor Congenital rubella infection is related with Type 1A 
diabetes 
NA 
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Table 1 continued 
Potential Differential Characteristics or 
Risk factors 
Type 1 Diabetes (T1DM) Type 2 Diabetes (T2DM) 
Specific diagnostic ICD-9 code  ICD-9 codes (250.X1 or 250.X3) may include  T1DM 
 
• 250.01
• 
: Diabetes mellitus without mention of 
complication, type1 [juvenile type], not stated as 
uncontrolled 
250.03
• 
: Diabetes mellitus without mention of 
complication, type 1 [juvenile type], uncontrolled 
250.11
• 
: Diabetes with ketoacidosis, type 1 [juvenile 
type], not stated as uncontrolled 
250.13
• 
: Diabetes with ketoacidosis, type 1 [juvenile 
type], uncontrolled 
250.21
• 
: Diabetes with hyperosmolarity, type 1 
[juvenile type], not stated as uncontrolled 
250.23
• 
: Diabetes with hyperosmolarity, type 1 
[juvenile type], uncontrolled 
250.31
• 
: Diabetes with other coma, type 1 [juvenile 
type], not stated as uncontrolled 
250.33
• 
: Diabetes with other coma, type 1 [juvenile 
type], uncontrolled 
250.41
• 
: Diabetes with renal manifestations, type 1 
[juvenile type], not stated as uncontrolled 
250.43: 
• 
Diabetes with renal manifestations, type 1 
[juvenile type], uncontrolled 
250.51
• 
: Diabetes with ophthalmic manifestations, 
type 1 [juvenile type], not stated as uncontrolled 
250.53
• 
: Diabetes with ophthalmic manifestations, 
type 2 [juvenile type], uncontrolled 
250.61
• 
: Diabetes with neurological manifestations, 
type 1 [juvenile type], not stated as uncontrolled 
250.63
• 
: Diabetes with neurological manifestations, 
type 1 [juvenile type], uncontrolled 
250.71
ICD-9 codes (250.X0 or 250.X2) may include T2DM 
: Diabetes with peripheral circulatory 
disorders, type 1 [juvenile type], not stated as 
uncontrolled 
 
• 250.00
• 
: Diabetes mellitus without mention of 
complication, type 2 or unspecified type, not 
stated as uncontrolled 
250.02
• 
: Diabetes mellitus without mention of 
complication, type 2 or unspecified type, 
uncontrolled 
250.10
• 
: Diabetes with ketoacidosis, type 2 or 
unspecified type, not stated as uncontrolled 
250.12
• 
: Diabetes with ketoacidosis, type 2 or 
unspecified type, uncontrolled 
250.20
• 
: Diabetes with hyperosmolarity, type 2 or 
unspecified type, not stated as uncontrolled 
250.22
• 
: Diabetes with hyperosmolarity, type 2 or 
unspecified type, uncontrolled 
250.30
• 
: Diabetes with other coma, type 2 or 
unspecified type, not stated as uncontrolled 
250.32
• 
: Diabetes with other coma, type 2 or 
unspecified type, uncontrolled 
250.40
• 
: Diabetes with renal manifestations, type 2 
or unspecified type, not stated as uncontrolled 
250.42
• 
: Diabetes with renal manifestations, type 2 
or unspecified type, uncontrolled 
250.50
• 
: Diabetes with ophthalmic manifestations, 
type 2 or unspecified type, not stated as 
uncontrolled  
250.52
• 
: Diabetes with ophthalmic manifestations, 
type 2 or unspecified type, uncontrolled 
250.60
 
: Diabetes with neurological 
manifestations, type 2 or unspecified type, not 
stated as uncontrolled 
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Table 1 continued 
Potential Differential Characteristics or 
Risk factors 
Type 1 Diabetes (T1DM) Type 2 Diabetes (T2DM) 
 • 250.73
• 
: Diabetes with peripheral circulatory 
disorders, type 1 [juvenile type], uncontrolled 
250.81
• 
: Diabetes with other specified manifestations, 
type 1 [juvenile type], not stated as uncontrolled 
250.83
• 
: Diabetes with other specified manifestations, 
type 1 [juvenile type], uncontrolled 
250.91
• 
: Diabetes with unspecified complication, type 
1  [juvenile type], not stated as uncontrolled 
250.93
• 
: Diabetes with unspecified complication, type 
1 [juvenile type], uncontrolled 
250.62
• 
: Diabetes with neurological 
manifestations, type 2 or unspecified type, 
uncontrolled 
250.70
• 
: Diabetes with peripheral circulatory 
disorders, type 2 or unspecified type, not stated as 
uncontrolled 
250.72
• 
: Diabetes with peripheral circulatory 
disorders, type 2 or unspecified type, uncontrolled 
250.80
• 
: Diabetes with other specified 
manifestations, type 2 or unspecified type, not 
stated as uncontrolled 
250.82
• 
: Diabetes with other specified 
manifestations, type 2 or unspecified type, 
uncontrolled 
250.90
• 
: Diabetes with unspecified complication, 
type 2 or unspecified type, not stated as 
uncontrolled 
250.92: Diabetes with unspecified complication, 
type 2 or unspecified type, uncontrolled 
*: Diagnosis of diabetes: (1) Symptoms (polyuria, polydipsia, unexplained weight loss) and a casual plasma glucose (any time of day without regard to time 
since last meal) ≥ 200 mg/dL (11.1 mmol/L) or (2) Fasting (no caloric intake for at least 8 hours) plasma glucose ≥ 126 mg/dL (7.0 mmol/L) or (3) 2-hour 
plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test (glucose load of 75 g anhydrous glucose dissolved in water or 1.75 g/kg body 
weight if weight < 43 kg).  The last two criteria should be confirmed on a second day if child /adolescent are asymptomatic. 
§: The level of C-peptide in the blood must be read with the results of a blood glucose test. Both these tests will be done at the same time. 
Abbreviations: BMI: body mass index; DKA: diabetic ketoacidosis; GAD: glutamic acid decarboxylase ; HLAs: histocompatibility loci antigens; IA2: islet 
antigen 512; NA: Not available; OHA: oral hypoglycemic agents  
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2.0  REVIEW OF THE REVELENT LITERATURE 
In this section, the current diabetic registries and their limitations were briefly reviewed.  We 
mainly focused on the statistical methods in the thesis.  
2.1 DIABETES REGISTRY AND ITS LIMITATIONS 
Information systems containing data on the level of care, including both processes and outcomes, 
offer a valuable tool for health systems. These information systems allow for continuous quality 
improvement, practice change, and improved outcomes. However traditional systems used to 
track quality of care, such as chart audit or patient and provider self-report, lack internal validity, 
are expensive, and inefficient.6  Administrative data also pose challenges.  The outcome as well 
as the explanatory variables may be continuous or discrete.  Relationships between variables 
often are nonlinear and involve complex interactions.  Missing values for both explanatory and 
outcome variables are fairly common, and outliers usually exist.  In addition, administrative data 
applied in clinical fields usually demand methods that are both easy to implement and easy to 
interpret. 
[Table 2] is adapted from Zgibor et al.6 and summarized a number of diabetes registries 
which are currently available in the United State and Canada.   Most of the databases are derived 
from homogenous populations from one health plan or insurer, which limit the translation of 
methodologies to other populations.  For example, the Veterans Health Administration (VA) 
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database includes only veterans,20 while the Center for Medicare and Medicaid Services serves 
mainly the elderly.21 Therefore, extrapolating results beyond these populations may not be 
appropriate.  Zgibor et al. developed a registry including more general population in a variety of 
settings,  and used two or more indicators or an out-patient diagnosis to identify diabetic patients 
with 99% to 100% sensitivity and 96% to 97% positive predictive value (PPV).6   Zgibor et al. 
pointed out using only one criterion would likely incorrectly classify patients (PPV: 21% to 
95%), except for outpatient diagnosis code for diabetes.6  However, none of the registries has 
further distinguished T1DM from T2DM, reflecting the lack of definitive diagnosis in clinical 
practice and possible recording bias.  This research will focus on the methodology to accurately 
distinguish T1DM from T2DM in an administrative and clinical diabetic database. 
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 Table 2: Summary of Populations, Case Definitions, and Validation Criteria for Existing Diabetes Database 
Organization, Year 
of Publication 
Population Case Definition Validation Process Positive 
Predictive 
Value 
Sensitivity Comment/Biases / Limitations 
Kaiser CA, 199722 85,209 Administrative database 
   
Diabetes medications/supplies 
(since 1994) or HbA1c ≥ 6.7 % 
(since 1991) or Primary or 
Secondary discharge diagnosis of 
diabetes (since 1971) or ER visit 
(since 1991) 
Mailed survey to 
~20,000 HMO 
enrollees (self-
reported diabetes) 
Not reported 90% One insurer 
Managed Care 
Organizations’ 
Diabetes Surveillance 
System (3 HMO’s), 
199823 
16,363 Administrative database (1993) 
 
Primary or secondary inpatient 
diagnosis of diabetes or Diabetes 
medications or 
2 or more outpatient visits or  
2 HbA1c test 
Not reported Not reported ≥2: 82%; 
≥3: 94%; 
4: 100% 
No length of stay data for out of HMO 
hospitalizations, or race 
Veteran’s 
Administration, 
199820 
139,646 Pharmacy derived database (1994) 
 
Diabetes medication or supplies 
Pharmacy 
department checked 
drug nomenclature 
Not reported Not 
reported 
Homogeneous population 
Medicare, 199924 1,941,517 Medicare claims data (1992-1993)  
 
≥1 indicator of an ICD-9 code for 
diabetes (including complications)  
1,135 of 7,562 
individuals that 
responded to a 
survey (self-
reported) 
Not reported 1 year 
period: up 
to 71.6% 
2 year 
period: up 
to 79.1% 
One insurer 
Using different Medicare claims file 
can construct a claims-based algorithm 
for identifying persons with diabetes 
with adequately sensitivity and high 
specificity, and good reliability. 
Puget Sound, 1999 
(detection of diabetes 
complications)25  
8,905 Administrative database 
 
Diabetes medications/supplies or 
GHb ≥ 7.5% or Discharge diagnosis 
of diabetes or random glucose > 
200 mg/dl  
FPG >140 mg/dl 
Random selection of 
471 individuals with 
diabetes  
90.4% Not 
reported 
One insurer 
  
15 
 
Table 2 continued 
Organization, Year 
of Publication 
Population Case Definition Validation Process Positive 
Predictive 
Value 
Sensitivity Comment/Biases / Limitations 
Kaiser OR, 200026 13,099 Diabetes medication, testing 
supplies, discharge notes, diabetes 
education contacts 
Random selection of 
425 medical charts 
Not reported 99% One insurer 
Indian Health 
Service, 200127 
6,870 Electronic health record 
> 1 ICD-9 code for diabetes 
Medication /supplies 
≥ 2 glucoses > 200 mg/dl 
Chart review on 462 
patients 
94% 92% Homogeneous population 
Kaiser CA, 200128 57,222 From 1994-1995 
Pharmacy prescriptions for diabetes 
medications 
Abnormal  HbA1c values (≥6.7%) 
in laboratory files 
Primary hospital diagnoses of 
diabetes 
Emergency department records of 
diabetes as the reason for visit 
Matched with 
>1,500 diabetes  
self-reported 
(through mailing) 
97.5% 90% One insurer 
 
Zgibor JC, 2007 
(UPMC) 6 
99,144 UPMC electronic clinical, 
administrative, and financial 
databases 
 
ICD-9 code 250 for either inpatient, 
emergency room or outpatient visits 
(treated as three indicators) or 
Any HbA1c result (regardless 
value) or 
A blood glucose > 200 mg/dl or 
Use of any diabetes medication 
Two validation 
studies: three 
outpatient clinics 
(validation 
population n = 254) 
and general internal 
medicine clinic 
(validation 
population n = 95) 
Single: 94% 
, 95%; 
 
≥ 2: 
 96%, 97% 
≥ 2: 100% Advantages: 80 insurers and 
heterogeneous population 
 
Disadvantages:  
No independent source or gold 
standard to quantify the cases might be 
missing; 
Missing laboratory data if samples 
were sent to non-UPMC laboratories; 
Medications data were only available 
for inpatients 
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Table 2 continued 
Organization, Year 
of Publication 
Population Case Definition Validation Process Positive 
Predictive 
Value 
Sensitivity Comment/Biases / Limitations 
Asghari S, PRIMUS 
group (Quebec, 
Canada), 20095 
263,213 
 
RAMQ and registry Med-Echo 
database (2002)- for incident 
diabetes cases 
 
NDDS definition: Two physician 
claims with a diagnosis on 2 
different days within 2 years or one 
hospital discharge with a diabetes 
diagnosis code in any field among 
16 diagnosis codes; 
To differentiate between prevalent 
and incident cases, a minimum 
diabetes-free retrospective 
observation (clearance) period was 
used. 
Not reported Not reported Not 
reported 
Advantage: Incidence of diabetes and 
kappa agreement by exclusion criteria 
and clearance period for 5 years and 10 
years are 1.3% and 0.957, and 1.24% 
and 1.00, respectively. A clearance 
period of 5 years or more is sufficient 
to improve performance to estimate of 
incident diabetes. 
This table is adapted from Zgibor et al. Diabetes Research & Clinical Practice 2007; 75:313-319, Table 1 
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2.2 THE CLASSIFICATION AND REGRESSION TREES (CART) METHOD OR 
TREE-STRUCTURED METHODS 
Tree-structured methods were introduced by social scientists.  The use of trees in regression 
dates back to the Automatic Interaction Detection (AID) program developed by Morgan and 
Sonquist in 1963 as a sequential procedure for the analysis of survey data.29  AID was suitable 
only for small to medium size data sets, and it could generate only regression trees.  Kass 
extended the methodology of AID to categorical data called CHAID in 1980.  The classic CART 
algorithm was introduced by Breiman, Friedman, Olshen, and Stone7 and is similar to the AID in 
that it uses binary splits to achieve the final classification.  However, the splitting mechanism 
used in CART is different from that of AID or CHAID.  CART uses the Gini-index to measure 
the homogeneity of cases at a leaf node, while AID uses the unexplained sum of squares and 
CHAID uses a Chi-square measure to evaluate splits based on the significance of differences in 
response distributions between groups.  
A classification or regression tree is the collection of many rules determined by a 
procedure known as “recursive partitioning”, while “linear combinations” are the primary 
mode of expressing relationships between variables in classical logistic and linear regression 
analyses.  A tree is typically shown growing upside down, beginning at its top node of the tree 
(called the root).  Trees are typically fit the “binary” recursive partitioning.  In the binary tree, 
each group or subgroup (parent node) within the scheme can potentially be further subdivided 
into two groups (two child nodes).    The term recursive is used to indicate that each child node 
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will, in turn, become a parent node.  At minimum, constructing a tree involves making decisions 
about three major issues.  The first choice is how splits are to be made: which explanatory 
variables will be used and where the split will be imposed.  A tree is grown that overfits the data.  
The second choice involves determining appropriate tree size from an overfitted tree, generally 
using a pruning process. The third choice is to determine how application-specific costs should 
be incorporated.  This might involve decisions about assigning varying misclassification costs or 
accounting for the cost of model complexity.  Then, a final tree is selected that represents the 
best estimate of the tree function for the data.  Throughout this thesis, we use the notation that 
Breiman et al.7 used to describe the original CART methodology. 
2.2.1 Notation and terminology 
A collection of M measurements (e.g. age, sex…., etc.), which is referred to as a measurement 
vector, is denoted by x = (x1, x2, …… , xM).  The measurement space X is defined as containing all 
possible measurement vectors.  Suppose that the cases or objects can be partitioned into J 
classes.  Number the classes 1, 2, ……, J and let C be the set of all disjoint and exhaustive 
classes; i.e., C = {1, 2,….., J}.  Therefore, given any x ∈ X, each possible measurement vector x 
will be uniquely assigned to a single class in C.  A classifier (or classification rule) is a function 
d(x) defined on X so that every x, d(x) is equal to one of the particular classes 1, 2,..…… , J.  In 
other words, d(x) ∈ {1, 2,….., J} ∀  x ∈ X.  A classifier is constructed based on past experience 
or data, summarized by a learning sample (or training dataset).  This consists of the 
measurement data on N cases observed in the past along with their actual classification. Thus, the 
learning sample is denoted by L, (1) 
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𝐿𝐿 = {(𝑥𝑥1, 𝑗𝑗1 ), … … , (𝑥𝑥𝑁𝑁 , 𝑗𝑗𝑁𝑁)} … … … … … … … … … … . . (1) 
An important criterion for a good classification procedure is that it not only produce 
accurate classifiers (within the limits of the data), but that it also provide insight and 
understanding into the predictive structure of the data.   
Given a classifier, that is, given a function d(x) defined on X taking values in C, we 
denoted by R*(d) as its “true misclassification rate”.  Two questions arise: does this classifier 
express the “truth” and how accurate is the estimate? Four types of internal estimates were 
developed to determine the accuracy.  These methods are resubstitution estimate, test sample 
estimation, cross-validation, and bootstrap estimation. However, Breiman, et al.7 found that the 
bootstrap estimation might not work well when applied to tree structure classifiers. 
The first method utilizing “resubstitution estimate” is the easiest, most commonly used, 
but least accurate.   After constructing a classifier d(x) and all of the cases in L are run through 
d(x), the proportion of cases misclassified is the resubstitution estimate.  Define the indicator 
function X(·) to be 1 if the statement inside the parentheses is true, otherwise zero.  The 
resubstitution estimate, denoted R(d), is (2) 
𝑅𝑅(𝑑𝑑) = 1
𝑁𝑁
�𝑋𝑋(𝑑𝑑(𝑋𝑋𝑛𝑛) ≠ 𝑗𝑗𝑛𝑛)𝑁𝑁
𝑛𝑛=1 … … … … … . (2) 
However, the problem with the resubstitution estimate is that it is computed using the 
same data used to construct d, instead of an independent sample.  All classification procedure 
attempts to minimize R(d), which tends to underestimate the true misclassification rate R*(d) of 
d(x).  
The “test sample method” randomly divides the learning sample L into two parts L1 and 
L2.  Only the cases in L1 are used to construct d(x).  Then the cases in L2 are used to estimate 
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R*(d).  If N2 is the number of cases in L2, the test sample estimate, Rts(d), is given by (3) 
𝑅𝑅𝑡𝑡𝑡𝑡(𝑑𝑑) = 1
𝑁𝑁2 � 𝑋𝑋(𝑑𝑑(𝑋𝑋𝑛𝑛) ≠ 𝑗𝑗𝑛𝑛)(𝑥𝑥𝑛𝑛 ,𝑗𝑗𝑛𝑛 )∈𝐿𝐿2 … … … … … . (3) 
Frequently, L1 consists of 2/3 of the data in the learning sample and L2 consists of the 
other 1/3, but we do not know of any theoretical justification for this 2/3, 1/3 split.  The classifier 
d(x) is constructed by using L1 and the misclassification rate is estimated by finding the 
proportion of cases misclassified by d(x) in L2.  Despite reducing the bias found in the 
resubstitution estimates, the disadvantage of test sample approach is that it reduces effective 
sample size.  This disadvantage is a minor difficulty if the sample size is large because a more 
accurate estimate is obtained. 
The last method, “cross-validation”, uses the entire sample to construct d(x).  This 
method works by randomly dividing the data into V equal-sized subsets and holding out one 
subgroup at a time to construct an independent d(x).  We used cross-validation to estimate the 
accuracy in this thesis, and the details related to cross-validation will be discussed further in 
Section 2.2.5. 
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2.2.2 Constructing a tree 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1. An Example of a Basic Tree 
 
The entire of construction of a tree revolves around three elements:  
(1) The selection of the splits. 
(2) The decision to declare a node as terminal or to continue splitting it. 
(3) The assignment of each terminal class to a node. 
Both Breiman et al.’s CART method and the S functions represent tree structured 
classifiers graphically by a binary tree, denoted by T (see Figure 1).7  Tree structured classifiers 
are constructed by splitting the dataset into two subsets. All of the observations in a dataset start 
Tree T 
t1 (root node) 
t2 t3 
t4 
t6
  
t7 
t8 t9 
t5 
t11 t12 t13 t10 
: Terminal node : Non-terminal node 
Split 1 
Split 2 
Split 3 
Split 4 Split 5 Split 6 
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in a “root node (or called parent node)”.  For a continuous variable, the allowed splits are of the 
form “xj < t versus xj ≥ t”.  For a categorical variable, the splits are of the same type “x ∈ subset 
i”.  The fundamental idea is to select each split of a subset so that the data in each of the 
descendant subsets are “purer” than the data in the parent subset.  These splits are generated in 
the following fashion. Starting with the first variable, x1, CART splits a variable at all of its 
possible split points.  At each possible split point of the variable, the sample splits into two 
binary child nodes.  Observations with a "yes" response to the question posed are sent to the left 
node tL and the "no" responses are sent to the right node, tR.  Some algorithms allow a linear 
combination of continuous variables to be split, and Boolean combinations to be formed of 
binary variables.30  CART then applies its goodness of split criteria to each split point and 
evaluates the decrease in impurity (or heterogeneity) due to the split.   
In Figure 1, T will be referred to as a tree and each element of T will be referred to as a 
node. The minimum element of a tree T is called the root node of T, denoted by root (T).   If p, t 
∈ T and t = left(p) or t = right(p), then p is called the parent of t. The root of T has no parent, but 
every other node has a unique parent. The data in the “root node” (t1) is first split into two 
subsets, t2 and t3.  The subsets are split into smaller subsets at the largest decrease of the node 
impurity (this will be described in detail later).  The node impurity is the largest when all classes 
are equally mixed together within a node and smallest when the node contains only one class.  
This process is repeated for each of the remaining variables at the root node.  CART ranks all of 
the best splits on each variable according to the reduction in impurity achieved by each split.  It 
selects the variable and its split point that most reduced impurity of the root or parent node.  
CART then assigns classes to these nodes according to a rule that minimizes misclassification 
costs.  Each subset is then considered for an additional binary split so that t2 could be split into t4 
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and t5 and t3 could be split into t6 and t7.  This process is repeated for each subset until the 
process can no longer be continued.  The goal is to have subsets of X that are “purer”, in that the 
majority of the measurement vectors in each subset belong to the same class. 
If the subset can be further split into two more subsets to achieve a more accurate 
classification tree then the subset is referred to as a nonterminal node, denoted with a circle in 
Figure 1. When a node t was reached such that no significant decrease in impurity was possible, 
then node t was not split and became a terminal node, denoted with a square in Figure 1.  
𝑇𝑇� denotes the collection of terminal nodes of T. The elements in T- 𝑇𝑇�   
are called non-terminal nodes.  When a terminal node, such as t5 in Figure 1, has been reached 
then all of the measurement vectors that belong to this node, {x : x ∈ t5}, are then designated as 
the same class.  
2.2.3 The splitting and stop-splitting rule 
Choosing the splits of the measurement space Χ is the first step to build a tree.  The fundamental 
idea is to have the majority of the subjects belong to the same class in each terminal node.  In 
developing a methodology to evaluate and compare potential splits, Breiman, et al. developed the 
goodness of fit criterion, which was originally derived from the impurity function, to evaluate 
and compare potential splits. 7 An impurity function Φ is defined  on the set of all J-tuples (p1, 
p2,…. pJ) satisfying pj ≥ 0,  j=1, 2,……J, ∑ 𝑝𝑝𝑗𝑗 = 1𝑗𝑗  and with properties:  
i. Φ achieves its maximum only at the point (1/j, 1/j,…, 1/j) 
ii. Φ achieves its minimum only at the points (1, 0, …,0), (0, 1, 0,…,0),…, (0,…, 0, 
1) 
24 
 
iii. Φ is a symmetric function of p1, p2,…. pJ. 
Given an impurity function and the conditional probabilities for the J classes at any node 
t, an impurity measure i(t) at any node t can be defined as (4) 
𝑖𝑖(𝑡𝑡) = Φ�𝑝𝑝(1|𝑡𝑡),𝑝𝑝(2|𝑡𝑡), … … … . ,𝑝𝑝(𝐽𝐽|𝑡𝑡)�… … … … … … . (4) 
A candidate split s will be selected based on its reduction of the impurity in the node t.  
Now, consider splitting the node t into nodes tL and tR by split s.  The proportions of the cases, pL 
and pR, in t will be sent into nodes tL and tR, respectively.  Thus, our measure of the decrease in 
impurity in node t due to split s is simply defined as (5),  
∆𝑖𝑖(𝑡𝑡, 𝑡𝑡) = 𝑖𝑖(𝑡𝑡) − 𝑃𝑃𝑅𝑅𝑖𝑖(𝑡𝑡𝑅𝑅) − 𝑃𝑃𝐿𝐿𝑖𝑖(𝑡𝑡𝐿𝐿) … … … … … … … . . (5) 
Then we consider the goodness of split Φ (s, t) to be ∆𝑖𝑖(𝑡𝑡, 𝑡𝑡).  We select the split s that 
maximizes ∆i(s, t) for each node. Once a node is split, the children nodes are evaluated to 
determine if they can be split. This process is repeated until every node contains a small number 
of subjects and to minimize overall tree impurity.   
There are many splitting criteria by which node impurity is minimized in a classification 
problem, but four commonly used metrics include “Misclassification error”, “Gini index”, 
“Entropy index”, and “Twoing’.  The misclassification error is simply the proportion of 
observations in the node that are not members of the majority of class in that node.  Gini index 
supposes that there are a total of K classes, each indexed by k. Let ?̂?𝑝𝑚𝑚𝑚𝑚  be the proportion of class 
k observations in node m.  The Gini index can then be written as ∑ ?̂?𝑝𝑚𝑚𝑚𝑚 (1 − ?̂?𝑝𝑚𝑚𝑚𝑚 ) = 1 −𝐾𝐾𝑚𝑚=1
∑ ?̂?𝑝𝑚𝑚𝑚𝑚
2
𝑚𝑚 .  This measure is frequently used in practice, and is more sensitive than the 
misclassification error to changes in node probability.  Entropy index is also called the 
information index, cross-entropy or deviance measure of impurity.  The entropy index can be 
written as ∑ ?̂?𝑝𝑚𝑚𝑚𝑚 𝑙𝑙𝑙𝑙𝑙𝑙?̂?𝑝𝑚𝑚𝑚𝑚𝐾𝐾𝑚𝑚=1 . This is more sensitive than misclassification error to change in node 
25 
 
probability.  Twoing, designed for multiclass problems, favors separation between classes rather 
than node impurity (heterogeneity).  Every multiclass split is treated as a binary problem.  Splits 
that keep related classes together are favored. The approach offers the advantage of revealing 
similarities between classes and can be applied to ordered classes as well. Breiman et al.7 
preferred the Gini index.  Breiman, et al.7 concluded that within a wide range of splitting criteria 
the properties of the final tree selected are surprisingly insensitive to the choice of splitting rule. 
The criterion used to prune or recombine upward is much more important.   
A stopping rule is to set a criterion for determining a terminal node. An early stopping 
rule was simple but unsatisfactory.  Set a threshold β > 0, and declare a node t terminal if the 
split that maximizes Δi(s,t) < β.  The concept of this stopping rule was plagued with problems.  
For example, the threshold β could be set too low that every terminal node has only one case and 
misclassification rate is zero.  In general, misclassification rate decreases while the number of 
terminal nodes increases.   These problems lead to the development of pruning.  The pruning 
process begins with a tree that is split until every node contains a small number of cases, forming 
the tree Tmax. Then children nodes are selectively pruned into the single parent upward toward 
the root node, creating more general trees.  Another stop-splitting rule is to declare a terminal 
node if the number of cases assigned to the node is less than some value or contains only 
identical measurement vectors. Measurement vectors in a terminal node are typically assigned to 
the class with the largest conditional probability, p(j|t).  Note that if the class prior probability 
is determined from the training data, i.e., π(j)=Nj/N, this rule assigns a terminal node to the class 
with the largest number of measurement vectors falling into the node.  The tree construction 
continues until the number of cases reaching each leaf is small (by default, Nj(t) < 20 in rpart, 
Nj(t) < 10 in tree; Nj(t) is the number of class j cases with x ∈ t).8 
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2.2.4 Class assignment for terminal nodes and resubstitution estimates 
The justification for the original S methodology is to view the tree as providing a probability 
model (hence the title “tree-based models” of Clark and Pregibon, 1992).  Of the three elements 
of tree construction, the assignment of classes to terminal nodes is the easiest to perform.  In the 
learning sample L, let N be the total number of cases and Nj be the number of cases in class j.  
Often the prior probability, π(j), are estimated to be Nj/N or supplied by the analyst.  In a node t, 
let N(t) be the total number of cases in L with xn ∈ t, and Nj(t) be the number of class j cases with 
x ∈ t. The proportion of the class j cases in L falling into node t is Nj(t)/Nj.  For a given set of 
priors, π(j) is interpreted as the probability that a class j will be presented to the tree. Thus, the 
resubstitution estimate for the probability that a case will be both in class j and fall into node t 
will be p(j ,t) = π(j)*Nj(t)/Nj.  The resubstitution estimate p(t) of the probability that any case 
falls into node t is defined by 𝑝𝑝(𝑡𝑡) = ∑ 𝑝𝑝(𝑗𝑗, 𝑡𝑡)𝑗𝑗 .     The resubstitution estimate of the conditional 
probability that a case is in class j given that it falls into node t is given by  
p(j|t) = p(j, t)/p(t) and satisfies ∑ 𝑝𝑝(𝑗𝑗|𝑡𝑡) = 1𝑗𝑗  .  When π(j) = Nj/N, so the p(j|t) are the relative 
proportions of class j cases in node t. 
Now, we attempt to develop a classification assignment rule. Suppose a tree T has been 
constructed and has a set of terminal nodes 𝑇𝑇� .  A class assignment rule assigns a class j ∈ {1, . . . 
, J} to each terminal node t ∈ 𝑇𝑇� .  The class assigned to t ∈𝑇𝑇�  is denoted by j(t). The joint 
probability of a case being from class j and falling into node t, p(j|t), is estimated from the data 
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as p(j,t) = π(j)Nj(t)/Nj.  By extension, the resubstitution estimate for the probability of any case 
falling into node t, p(t) is (6),  
𝑝𝑝(𝑡𝑡) = �𝜋𝜋𝑗𝑗𝑁𝑁𝑗𝑗 (𝑡𝑡)
𝑁𝑁𝑗𝑗
𝑗𝑗
… … … … … … … … … … … … … . … . (6) 
The resubstitution estimate for the probability of misclassification given that a case falls 
into node t is given by (7), 
 
𝑃𝑃(𝑗𝑗|𝑡𝑡) = 𝑝𝑝(𝑗𝑗, 𝑡𝑡)
𝑝𝑝(𝑡𝑡)    𝑤𝑤𝑖𝑖𝑡𝑡ℎ �𝑝𝑝(𝑗𝑗|𝑡𝑡) = 1 … … … … … … . (7)
𝑗𝑗
 
When the π(j) are estimated from the data using Nj(t)/N(t), p(j|t) can be estimated by (8), 
𝑃𝑃(𝑗𝑗|𝑡𝑡) = 𝑁𝑁𝑗𝑗 (𝑡𝑡)
∑ 𝑁𝑁𝑗𝑗𝑗𝑗
=  𝑁𝑁𝑗𝑗 (𝑡𝑡)
𝑁𝑁(𝑡𝑡) … … … … … … … … … … … … . . (8) 
For any class assignment rule j(t), ∑ 𝑝𝑝(𝑗𝑗|𝑡𝑡)𝑗𝑗≠𝑗𝑗 (𝑡𝑡)  is the resubstitution estimate of the 
probability of misclassification given that a case falls into node t. We take as our class 
assignment rule j*(t) that minimize the resubstitution estimate, that is, if 𝑝𝑝(𝑗𝑗|𝑡𝑡) =  max𝑖𝑖 𝑝𝑝(𝑖𝑖|𝑡𝑡)  
then j*(t)=j.  If two or more classes achieve the maximum, then assign j*(t) arbitrarily as any one 
of the maximizing classes. 
Using this class assignment rule, we get the resubstitution estimate r(t) of the probability 
of misclassification, given that a case fall into node t as 𝑟𝑟(𝑡𝑡) = 1 −  max𝑗𝑗 𝑝𝑝(𝑗𝑗|𝑡𝑡).  When we 
define the joint probability R(t) that a case falls into node t and is misclassified as R(t) = r(t)p(t), 
then the resubstitution estimate for the overall misclassification rate R*(T) of the tree classifier T 
is (9) 
𝑅𝑅(𝑇𝑇) = �𝑅𝑅(𝑡𝑡) … … … … … … … … … … … … … … … . (9)
𝑡𝑡∈𝑇𝑇�
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Since misclassifying a case might be worse in a realistic setting, the idea of including a 
set of misclassification costs C(i|j) was introduced.  The misclassification costs refer to the 
penalty that one assigns to the different possible misclassifications.  For example, when trying to 
classify patients into whether they are at high risk or low risk for a certain type of cancer, we 
may feel that there is little penalty for identifying someone as high risk when in fact they are low 
risk. However, if a patient is classified as low risk when they are really high risk, the 
repercussion of this misclassification is much worse.  Thus, C(i|j) is the cost of misclassifying a 
class j object as a class i and satisfies in (10) and (11): (𝑖𝑖) 𝐶𝐶(𝑖𝑖|𝑗𝑗) ≥ 0, 𝑖𝑖 ≠ 𝑗𝑗, … … … … … . (10) (𝑖𝑖𝑖𝑖) 𝐶𝐶(𝑖𝑖|𝑗𝑗) = 0, 𝑖𝑖 = 𝑗𝑗… … … … . … (11) 
Given a node t with estimated node probability p(j|t), if a randomly selected object of 
unknown class falls into t and is classified as class i, then the estimated expected 
misclassification cost is shown in (12). 
𝐸𝐸𝑡𝑡𝑡𝑡𝑖𝑖𝑚𝑚𝐸𝐸𝑡𝑡𝐸𝐸𝑑𝑑 𝐸𝐸𝑥𝑥𝑝𝑝𝐸𝐸𝑒𝑒𝑡𝑡𝐸𝐸𝑑𝑑 𝑚𝑚𝑖𝑖𝑡𝑡𝑒𝑒𝑙𝑙𝐸𝐸𝑡𝑡𝑡𝑡𝑖𝑖𝑚𝑚𝑖𝑖𝑒𝑒𝐸𝐸𝑡𝑡𝑖𝑖𝑙𝑙𝑛𝑛 𝑒𝑒𝑙𝑙𝑡𝑡𝑡𝑡 = �𝐶𝐶(𝑖𝑖|𝑗𝑗)𝐽𝐽
𝑗𝑗=1 𝑝𝑝(𝑗𝑗|𝑡𝑡) … … … … … … . . (12) 
A natural node rule to develop our class assignment rule j*(t) is to select i to minimize the 
estimated expected misclassification cost.  Therefore, the resubstitution estimate r(t) of the 
expected misclassification cost for a node t is (13) 
𝑟𝑟(𝑡𝑡) = min
𝑖𝑖
�𝐶𝐶(𝑖𝑖|𝑗𝑗)𝐽𝐽
𝑗𝑗=1 𝑝𝑝(𝑗𝑗|𝑡𝑡), … (13) 
and the resubstitution estimate R(T) of the misclassification cost of the tree T is (14) 
𝑅𝑅(𝑇𝑇) = �𝑟𝑟(𝑡𝑡)𝑝𝑝(𝑡𝑡) = �𝑅𝑅(𝑡𝑡), 𝑤𝑤ℎ𝐸𝐸𝑟𝑟𝐸𝐸 𝑅𝑅(𝑡𝑡) = 𝑟𝑟(𝑡𝑡)𝑝𝑝(𝑡𝑡).
𝑡𝑡∈𝑇𝑇�𝑡𝑡∈𝑇𝑇�
… … … … … . (14) 
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2.2.5 Selecting the best tree 
The best tree is one that is small, easily interpretable but still retains the ability to classify 
correctly.  Appropriate tree size can be determined in a number ways.  One way is to set a 
threshold for the reduction in impurity measure, below which no split will be made.  Depending 
on the threshold, the splitting was either too soon at some terminal nodes or continued too far in 
other parts of the tree.  A preferred approach is to grow an overly large tree until some minimum 
node size is reached, and then prune the tree back to an optimal size.  Cross-validation or test 
sample estimates can be used to select the subtree with the lowest estimated misclassification 
rate. 
 The pruning process results in a decreasing sequence of subtrees, T1 > T2> …… >{t1}, 
where Tk=T(αk) and α1=0.  We have to select one of these as the optimum-sized tree.  Each tree 
in the sequence is best for some range of the complexity parameter α in that it minimizes the 
cost-complexity function. Optimal size can be determined using an independent test sample or 
cross-validation.  If the sample size is sufficiently large, the data can be divided into two subsets 
randomly, namely, one for training and other for testing.  Defining sufficiently large is problem 
specific, but one rule of thumb in classification problem is to allow a minimum of 200 
observations for a binary classification model, with an additional 100 observations for each 
additional class.   An overly large tree is grown on the training data.  Then, using the test set, 
error rates are calculated for the default tree as well as all smaller subtrees.  The subtree with the 
smallest error rate based on the independent test set is then chosen as the best tree.   
The method that we will focus on to determine the best tree is cross-validation. If the 
sample size is not large, it is necessary to retain all the data for training purposes. However, 
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pruning and testing must be done using independent data.  Cross-validation involves randomly 
dividing the data into V roughly equal groups. One of the V portions is left out while the 
remaining portions all are used to build a model.  The portion not used in building the model is 
used to assess the accuracy of the current model. This process is repeated for each of the other V 
−1 portions and then the V estimates are averaged to get the final cross-validation estimate of 
model accuracy. The most common cross-validation is the 10-fold cross-validation which 
subtrees of different sizes are constructed with 90% of the data and their misclassification rates 
on the remaining are computed.  This process is done 10 times with each 1/10 of the data held 
out one time. The misclassification rates are aggregated over the replications.  Finally, the 
optimal tree size is the one whose aggregated misclassification rate is smallest. 
Cross-validation can be implemented in the complex sequence of trees T1 > T2 > …….> 
{t1} in the following way.  In V-fold cross-validation, the learning sample L is divided randomly 
into V equal (nearly) subsets. Let Lv be the vth portion of the learning sample and L(v) represent 
the entire learning sample missing only the vth portion. We already have our sequence of trees 
and critical values of α based on the entire learning sample.  Now we must repeat the tree 
growing and cost-complexity pruning steps for L(1), L(2), . . . , L(v). For L(1), we will obtain a 
sequence of trees T1 (1) >T2 (1)> …..> {t1} and a sequence of critical values α1(1)< α2(1)< . . . < 
αk1
(1) where k1 is the number of subtrees in the previous sequence.  A similar sequence of trees 
and critical values will be obtained for the other V − 1 sets. 
Let T (1)(α′j) be the minimal cost-complexity tree for complexity parameter α′j based on 
L(1). The minimal cost-complexity tree can be found for the other V − 1 sets giving us T (1)(α′j), T 
(2)(α′j), . . . , T (V)(α′j).  Now define 
Nij(v) = the number of class j cases in Lv classified as i by T (V)(α′j), and (15) 
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𝑁𝑁𝑖𝑖𝑗𝑗 = � 𝑁𝑁𝑖𝑖𝑗𝑗 (𝑣𝑣)𝑉𝑉
𝑣𝑣=1 … … … … … … … … … … . (15) 
Each case in L appears in one and only one test sample Lv.   Therefore, the total number 
of class j observations in L is Nj.  The T(v)(α) should have about the same classification accuracy 
as T(α) for V large.  Hence, we make the cross-validation estimate for the probability of 
classifying a case as i given that it is j for T(α) as QCV(i|j) = Nij / Nj.  For the prior probability 
{π(j)} is given or estimated,  set the cross-validation estimate for the cost associated with class j 
by (16) 
𝑅𝑅𝐶𝐶𝑉𝑉(𝑗𝑗) = �𝐶𝐶(𝑖𝑖|𝑗𝑗)𝑄𝑄𝐶𝐶𝑉𝑉(𝑖𝑖|𝑗𝑗)
𝑖𝑖=1 … … … … … . (16) 
 
and the cross-validation estimate for the cost of T(α) by (17) 
𝑅𝑅𝐶𝐶𝑉𝑉(𝑇𝑇(𝛼𝛼)) = �𝑅𝑅𝐶𝐶𝑉𝑉
𝑖𝑖=1 (𝑗𝑗)𝜋𝜋(𝑗𝑗) … … … … … … . (17) 
 
If the data from L is used to estimate the priors, then π(j) = Nj/N and the cross-validation estimate 
reduces to (18) 
𝑅𝑅𝐶𝐶𝑉𝑉(𝑇𝑇(𝛼𝛼)) = 1
𝑁𝑁
�𝐶𝐶(𝑖𝑖|𝑗𝑗)𝑁𝑁𝑖𝑖𝑗𝑗 .
𝑖𝑖 ,𝑗𝑗 … … … … … … … (18) 
In the unit cost case, (18) simply shows the proportion of the test set cases misclassified.  
Selection of the right sized tree is now obtained by finding T(α′j0)) such that (19). 
𝑅𝑅𝐶𝐶𝑉𝑉�𝑇𝑇(𝛼𝛼𝑗𝑗0′ )� = min𝑗𝑗=1 𝑡𝑡𝑙𝑙  𝑚𝑚 𝑅𝑅𝐶𝐶𝑉𝑉 �𝑇𝑇�𝛼𝛼𝑗𝑗′�� . … … … (19) 
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Then use RCV(T(α′j0)) as an estimate of the misclassification cost.  If the sample is small, 
cross-validated trees tend to be conservative in the direction of overestimating misclassification 
costs.  Now, the question is how large to take V?  Breiman et al. stated that taking V=10 gives 
adequate accuracy.7 In some examples, smaller values of V also give sufficient accuracy.  
However, they did not come across any situations where taking V larger than 10 gave a 
significant improvement in accuracy for the tree selected. 
As mentioned before, one of the advantages of CART is their ability to accommodate 
missing values.  If an outcome variable is missing, that observation can be excluded from the 
analysis, or in the case of classification problem, treated as a new class to identify any potential 
patterns in the loss of information.  If explanatory variables are missing, tree can use surrogate 
variables in their place to define the split.  Alternatively, an observation can be passed to the next 
node using a variable that is not missing for that observation.  The easiest approach is to treat the 
missing attribute as a distinct value and to assign all samples with missing values to the same 
node.  Breiman, et al.7 introduced surrogate splits to deal with missing attributes.  Suppose that a 
measure of similarity between any two splits s, s’ of a node t.  If the best split of node t is the 
split s on the variable xm, find the split s’ on the variable other than xm that is most similar to s.  
We call s’ the best surrogate for s.  Similarly, we can define the second best surrogate, third best, 
and so on.  In other words, if an observation is missing a value for the best split, then it is 
classified using the first surrogate split. If that value is missing then the second surrogate split is 
used, and so on. If an observation is missing all the surrogate splits then the default rule max 
(pL;pR), where the observation is sent to the child with the largest relative frequency at that node, 
is used. The surrogate splits have advantages because they use other available information to 
make the split. Breiman, et al.7 also proposed ranking the importance of variables through 
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surrogate splits.  The ranking of a variable that does not appear in a split on the final tree, 
indicates that this variable is masked by other variables.   
2.2.6 Regression tree  
The underlying ideas for classification and regression trees are quite similar, but terminology 
differs.  However, several things become simpler because there are no priors so each case is 
weighted equally.  The prediction for a regression tree is constant over each cell of the partition 
of X induced by the leaves of the tree.  We define that the predictor d(x) is a real-value function 
on X.  Thus d(x) produces real numbers not classes.  A learning sample L consists of the 
observations (x1, y1), (x2, y2),……, (xN, yN) where x is a vector of measurements that hopefully 
explain the real valued response y.  The misclassification rate of the classifier d(x) is denoted by 
R(d). In a regression tree, the estimated mean squared error for d(x) will be represented as 
misclassification rate R(d) to measure the accuracy of the predictor.  For a given rule d(x), the 
resubstitution estimate for the mean squared error is (20). 
𝑅𝑅(𝑑𝑑) = 1
𝑁𝑁
�(𝑦𝑦𝑛𝑛 − 𝑑𝑑(𝑋𝑋𝑛𝑛))2.
𝑛𝑛
… … … … … . . (20) 
𝑦𝑦�(𝑡𝑡), the average of yn for all cases that fall into node t, is used to minimize R(d).  
Therefore, our estimate for the mean squared error of the tree T is (21). 
𝑅𝑅(𝑇𝑇) = 1
𝑁𝑁
� � (𝑦𝑦𝑛𝑛 − 𝑦𝑦(𝑡𝑡)������)2
𝑛𝑛 :𝑋𝑋𝑛𝑛∈𝑡𝑡𝑡𝑡∈𝑇𝑇� … … … … … . (21) 
If R(t) is the within node sum of squares divided by N, then R(T) can be written as (22). 
𝑅𝑅(𝑇𝑇) = �𝑅𝑅(𝑇𝑇)
𝑡𝑡∈𝑇𝑇�
… … … … … … … … … … . . (22) 
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Finding the split of t into tL and tR which decreases R(T) the most is the way to determine what 
the best split of a current terminal node t. Let s be a candidate split in the set of possible splits S. 
Let (23) be 
∆𝑅𝑅(𝑡𝑡, 𝑡𝑡) = 𝑅𝑅(𝑡𝑡) − 𝑅𝑅(𝑡𝑡𝐿𝐿) − 𝑅𝑅(𝑡𝑡𝑅𝑅) … … … … . (23) 
and find the best split s* satisfying in (24). 
𝑆𝑆∗ = argmax
𝑡𝑡∈𝑆𝑆
∆𝑅𝑅(𝑡𝑡, 𝑡𝑡) … … … … … … … … . . (24) 
We used the same method to grow a regression tree as for a classification tree.  Tmax is 
created by splitting to minimize R(T).  The tree is declared Tmax once each terminal node contains 
at most some small number of observations (usually 5).  Minimal error-complexity pruning is 
performed the same way as in classification trees.  Define the error-complexity measure as (25). 
𝑅𝑅𝛼𝛼(𝑇𝑇) = 𝑅𝑅(𝑇𝑇) + 𝛼𝛼�𝑇𝑇��… … … … … … … (25) 
 
We obtain our sequence of trees and critical values based on the entire learning sample.  
Let dk(x) be the prediction rule associated with the tree Tk.  L is randomly divided into V groups.  
In cross-validation, we find the sequence of trees and critical values for each of the V possible 
groups formed by leaving out one of the V portions.  For each of the V sequence of trees and 
critical values, we can form the function T (V)(α) that is the minimal error-complexity tree for 
parameter α in the vth sequence of trees.  The cross-validation estimate for the mean squared 
error of tree Tk is (26) 
𝑅𝑅𝐶𝐶𝑉𝑉(𝑇𝑇𝑚𝑚) = 1𝑁𝑁 ∑ ∑ (𝑦𝑦𝑛𝑛 − 𝑑𝑑𝑚𝑚(𝑣𝑣)(𝑥𝑥𝑛𝑛))2𝑛𝑛 :(𝑥𝑥𝑛𝑛 :𝑦𝑦𝑛𝑛 )∈𝐿𝐿𝑣𝑣𝑉𝑉𝑣𝑣=1 ………………(26) 
 
which leads to the cross-validation estimate, (27). 
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𝑅𝑅𝐸𝐸𝐶𝐶𝑉𝑉(𝑇𝑇𝑚𝑚) = 𝑅𝑅𝐶𝐶𝑉𝑉(𝑇𝑇𝑚𝑚)𝑅𝑅(𝑦𝑦�) … … … … … … … … … . (27) 
2.3 S-PLUS AND “RECURSIVE PARTITIONING (RPART)” FUNCTIONS 
S-PLUS is an implementation of the language S developed at Bell Laboratories by Becker, 
Chamberlain and Wilks.8  The “recursive and partitioning and regression tree (rpart)” library 
and affiliated packages is part of the R public domain statistical software and can be downloaded 
into S-Plus.  In most details, “rpart” function follows many ideas quite closely found in CART 
by Breiman et al.7  Because CART™ is the trademarked name of a particular software 
implementation of the CART ideas and “tree” has been used for the S-Plus routines, different 
acronym “rpart” was chosen to call the library connected in the S-Plus.  The introduction within 
S of tree-based models described by Clark and Pregibon in 1992 made the methods much more 
freely available through function “tree” and its support functions.30  The library section “ 
(rpart)” differs from the “tree” function mainly in its handling of surrogate variables.8  The 
“tree” function has some advantages, mainly in showing some process in more detail.  We used 
the “rpart” function in this thesis because it provides a faster for fitting trees to a large dataset.30    
How is the “rpart” package in conjunction with TIBCO Spotfire S+ 8.1 (TIBCO 
Software)?  A powerful feature of S-PLUS is to allow users to extend its functionality and 
interface with other languages, namely, C and Fortran.  By using other languages, users can 
combine the speed and efficiency of compiled code with the robust, flexible programming 
environment of S-PLUS.  Although S is a versatile language with many routines already 
included, same procedures are not covered.  Fortunately, the core routines are easily augmented 
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with additional user-written routines, which can be loaded into S-PLUS.  These routines are 
usually provided in what S-PLUS calls a “library”.  We can easily package up user-created 
functionality in order to share it with other users through the S-PLUS libraries.8  The “rpart” 
package is written in C language and implements classification and regression trees defined by 
Breiman, et al.7 and Therneau and Atkinson31.  The “rpart” is loaded and called from within S-
PLUS and returns a standard S-PLUS tree object, which can then be manipulated using other S-
PLUS visualization and statistical functions.  Hence, the “rpart” package contains both C and S 
code. The purpose of the C code is to improve on the cpu time required for lengthy computations 
that are performed during the recursive partitioning process. 
The “rpart” algorithm that we mainly used in this thesis was developed by Therneau and 
Atkinson.31  The “rpart” programs build classification and regression trees of a very general 
structure using a two stage procedure; the resulting models can be represented as binary trees.31 
First, the single variable is found which best splits the data into two groups.  The data is 
separated and then this process is applied to each of sub-groups recursively, and so on 
recursively until the subgroups either each a minimum size or no improvement can be made.  
The initial default tree may be too large and complex.  The second stage of the “rpart” program 
consists of using cross-validation to prune back the default tree.   A cross validated estimate of 
risk was computed for a nested set of subtrees.  The final model is the subtree with the lowest 
estimated risk.  Two types of decision trees are distinguished: regression trees for continuous 
responses and classification tree for categorical responses.  The types of endpoints that “rpart” 
handles include classification (such as yes/no), continuous variables (such as blood pressure), 
Poisson counts (such as the numbers of fractures in Medicare patients), and survival information 
(such as time to death).    
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2.3.1 Building a tree and splitting criteria 
The “rpart” uses a measure of impurity of a node to build a binary tree.  Let f be some impurity 
function and define the impurity of a node A as (28). 
𝐼𝐼(𝐴𝐴) = �𝑚𝑚(𝑝𝑝𝑖𝑖𝐴𝐴) … … … … … … … . . (28)𝐶𝐶
𝑖𝑖=1  
where piA is the proportion of those in A that belong to class i for future observations.  Since we 
would like I(A) =0 when A is pure, f must be concave with f(0) = f(1) = 0.  Two candidates for f 
in the “rpart” program are the entropy (or information) index, f(p) = -p log(p) and the Gini 
index, f(p) = p(1-p). We then use the split with maximal impurity reduction in (29). 
∆𝐼𝐼 =   𝑃𝑃(𝐴𝐴)𝐼𝐼(𝐴𝐴) − 𝑝𝑝(𝐴𝐴𝐿𝐿)𝐼𝐼(𝐴𝐴𝐿𝐿) − 𝑝𝑝(𝐴𝐴𝑅𝑅)𝐼𝐼(𝐴𝐴𝑅𝑅) … … … … … … (29) 
2.3.2 Pruning the tree 
The initial tree possibly too large or complex, and we have to decide how much of that model to 
retain.  The “rpart” uses a likelihood-based pruning criterion as a way to prune branches of the 
overfitted tree.  Let T1, T2, …, Tk be the terminal nodes of a tree T, |T| be the number of terminal 
nodes, R(T) be the risk of T and R(T0) be the risk for the zero split tree.  Define the cost for the 
tree to be (30). 
𝑅𝑅𝛼𝛼(𝑇𝑇) = 𝑅𝑅(𝑇𝑇) + 𝛼𝛼|𝑇𝑇| … … … … … … . (30) 
where  𝑅𝑅(𝑇𝑇) =  ∑ 𝑃𝑃(𝑇𝑇𝑖𝑖)𝑅𝑅(𝑇𝑇𝑖𝑖), 𝑃𝑃(𝑇𝑇𝑖𝑖) 𝑖𝑖𝑡𝑡 𝑡𝑡ℎ𝐸𝐸 𝑝𝑝𝑟𝑟𝑙𝑙𝑝𝑝𝐸𝐸𝑝𝑝𝑖𝑖𝑙𝑙𝑡𝑡𝑦𝑦 𝑙𝑙𝑚𝑚 𝑛𝑛𝑙𝑙𝑑𝑑𝐸𝐸 𝑇𝑇𝑖𝑖 ,𝑚𝑚𝑖𝑖=1  and α is a complexity 
parameter between 0 and ∞.  Therefore the risk of T is the sum of all the probabilities of each 
split tree multiplied by the risk of each split tree. Tα is the subtree of the full model that has 
38 
 
minimal cost. Therefore, we can define Tα as the smallest tree T for which Rα(T) is minimized.  
In comparison to regression, |T| is analogous to the model degrees of freedom and R(T) to the 
residual sum of squares.   
The “rpart” then uses V-fold cross-validation to choose the best value for α by the 
following step:  
i. Fit the full model on the data set and compute measures of impurity  
ii. Divide the data randomly into roughly equal V sized groups where V is an 
integer usually between 5 and 10.  V-1 groups, the training set, are used to 
generate the model separately and the remaining portion, the test set, is used to 
evaluate the model. This step is repeated until all test sets have been used in 
model evaluation.    
iii. The results of these trees are averaged for all the combinations where one of the 
groups is withheld.  For that complexity parameter with the smallest risk is 
chosen as the best-pruned tree.  The default for the “rpart” is V=10, called 10-
fold cross-validation. 
In actual practice, we may use instead the 1-SE rule.7, 31   A plot of complexity 
parameters versus risk often has an initial sharp drop followed by a relative flat plateau and then 
a slow rise.  The choice of complexity parameter among those models on the plateau can be 
essentially random.  To avoid this, both an estimate of the risk and its standard error are 
computed during the cross-validation.  Any risk within one standard error of the achieved 
minimum is marked as being equivalent to minimum which is considered to be part of the flat 
plateau.  Then the simplest model among all those “tied” on the plateau is chosen. 
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2.3.3 Missing data and surrogate variables 
Most statistical procedures deal with missing data by excluding incomplete observations in the 
analysis.  The “rpart” handles missing data differently. Any observation with values for the 
dependent variable and at least one independent variable will be included in the modeling.  In 
other words, the “rpart” by default, removes only those rows for which either the response y or 
all of the independent variables are missing.  This ability to retain partially missing observations 
is perhaps one of the most useful features of the “rpart” function. With missing data, the object 
is still to maximize the reduction of impurity in (32). 
∆𝐼𝐼 =   𝑃𝑃(𝐴𝐴)𝐼𝐼(𝐴𝐴) − 𝑝𝑝(𝐴𝐴𝐿𝐿)𝐼𝐼(𝐴𝐴𝐿𝐿) − 𝑝𝑝(𝐴𝐴𝑅𝑅)𝐼𝐼(𝐴𝐴𝑅𝑅) … … … … … . (32) 
The first term stays the same for all variables and splits irrespective of missing data 
because it is calculated over all observations in node A, but the last two terms (dealing with the 
right and left children nodes) are somewhat modified.  Firstly, the impurity indices of both child 
nodes, I(AL) and I(AR), are calculated only over observations that are not missing a particular 
predictor.  Secondly, the two probabilities for both the left and right child nodes, p(AL),p(AR), are 
also calculated only over observations that are not missing a particular variable, but they are later 
adjusted so that they sum to the probability of node A (p(A)).  This takes some extra effort while 
building a tree, but ensures that the probabilities of the terminal node will sum to one. 
Once a splitting variable and it’s split cut point have been decided, what is to be done 
with observations missing that variable?  The “rpart” uses surrogate variables.   As mentioned 
before, the missing values are ignored and the probabilities and impurity measures are calculated 
from the non-missing values of that variable.  For any observations with a missing value for the 
split variable, the surrogate variables are ranked and surrogate splits are used to allocate the 
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missing cases to the child nodes.  Any observation that is missing the first surrogate split variable 
is then classified using the first surrogate variable, or if missing that, the second surrogate is 
used, etc.  If an observation is missing all the surrogates the blind rule (i.e., go with the majority) 
is used.  In addition, the “rpart” routines impose one more constraint during the construction of 
surrogates: a candidate surrogate must send at least two cases down each branch (i.e., at least two 
to right and two to left). 
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3.0  METHODS 
Our goal is to develop a set of criteria to distinguish T1DM from T2DM in a large administrative 
database.  The several steps involved in developing a clinical prediction rule to distinguish 
T1DM from T2DM in an administrative database include (1) assemble the cohort; (2) decide 
which predictors to obtain from those available in an administrative database; (3) identify cases 
of T1DM and T2DM (outcome); and (4) build a tree-model and estimate the misclassification 
rate of the rule.  
3.1 THE SETTING AND ASSEMBLE THE COHORT  
Because we sought a potentially generalizable and accurate predictive rule to identify people 
with T1DM and T2DM that could applied in heterogeneous clinical settings, we used the 
database from the UPMC.   UPMC is one of the largest non-profit integrated health care systems 
in the United States.   UPMC integrates 20 academic, community, and specialty hospitals and 
400 outpatient sites, employs 2,700 physicians and also offers rehabilitation, retirement and 
long-term care facilities, pharmacy services, a managed care health plan, and a community health 
division.32 Each year, UPMC hospitals have more than 187,000 inpatient admissions, 4.5 million 
outpatient visits and 480,000 emergency visits.32  Of the 23.6 million people with diabetes 
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nationwide, Pennsylvania ranked sixteenth for the percentage of the adults who had ever been 
told by a doctor that they had diabetes (8%, about  764,000 people).33  UPMC provides services 
for the large majority of people with diabetes throughout the Western Pennsylvania.34  A large 
diverse cohort maximizes the chance that the clinical prediction rule will generalize to other 
populations of diabetic patients.  One empirical rule of the size of the training dataset is to 
include five patients in the smallest outcome category for every clinical predictor in the rule. 
3.2 DIABETES REGISTRY FROM THE MEDICAL ARCHIVAL RETRIEVAL 
SYSTEM (MARS) DATA 
UPMC has used an electronic medical record called MARS since 1987.  MARS is a repository of 
information forwarded from the health system’s electronic clinical, administrative, and financial 
databases.  Laboratory results and patient demographics, visits, and charges are captured into 
MARS.  MARS is indexed on every word in the medical records, and is capable of recovering all 
encounters for a given patient between specified dates.  MARS-based data sources used to 
establish the diabetes registry included: (1) Medical Records Discharge Abstract file, consisting 
of all visits coded by the Medical Records Department, with up to 25 ICD-9 diagnosis codes 
assigned per patient; (2) the Hospital Laboratory Information System that includes inpatient, 
emergency room, hospital-based clinics, outpatient surgery, and mail-in specimens. Laboratory 
data are sent to MARS using the Misys® laboratory information system, which supports all of 
the UPMC hospitals and clinics; (3) the Hospital Pharmacy Information System which includes 
inpatient information on medication dispensed in the emergency room, hospital-based clinics, 
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and outpatient surgery settings.  The MARS database is continually audited by Internal Audit at 
UPMC as well as part of the Capability Maturity Model process that is required of all UPMC 
databases and part of the UPMC policies and procedures for maintaining data integrity.6 
        We examined data for the period 1/1/2000-09/30/2009.  In total, 140,781,751 lab reports, 
5,720,470 visits and 139,750,158 charges records representing approximately 290,552 patients 
with unique accounts were searched.  First, the initial source population was identified by the 
presence of any one of the following six criteria: ICD-9 code 250 (diabetes) for either inpatient, 
emergency room or outpatient visits (treated as three separate indicators); any HbA1c result 
(regardless of value, reference range 4.3-6.1); a blood glucose >200 mg/dl; or use of any diabetes 
medication (acarbose, acetohexammide, chlorpropamide, glimepiride, glipizide, glucagon, 
glyburide, insulin, metformin, miglitol, pioglitazone, repaglinide, rosiglitazone, tolazamide, 
tolbutamide, troglitazone).6  According to the crteria from Zgibor et al.,6 we used two or more of 
the above indicators or an out-patient-diagnosis to identify potential diabetic patients.   80,145 
patients who did not meet criteria and 807 patients younger than 18 years of age were excluded.  
Each patient is represented only once in the database.  We identified 209,642 potential diabetic 
patients with age ≥18.  Data cleaning, formatting, and recoding were done using SAS 9.2 (SAS 
Institute Inc., Cary, NC). 
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3.3 POTENTIAL PREDICTORS AND RULES TO IDENTIFY POTENTIAL T1DM 
AND T2DM CASES IN THE MARS DATASET 
Unfortunately, not all of the potential variables in the Table 1 can be obtained from an MARS 
database.  As shown in the Table 3,  we were able to obtain 32 variables from the MARS 
database including ICD-9 codes for T1DM (250.x1 or 250.x3) and T2DM (250.x0 or 250.x2), 
insulin use, pramlintide use, other oral hypoglycemia agents (OHA) use (acarbose, 
acetohexamide, chlorpropramide, exenatide, glimepiride, glipizide, glucagon, glyburide, 
metformin, miglitol, nateglinide, pioglitazone, repaglinide, rosiglitazone, sitagliptin, 
tolazamide, tolbutamide, troglitazone), DKA, hypoglycemic coma, comorbidities (Addison, 
thyroid, and celiac diseases), and complications (myocardial infarction (MI), coronary artery 
bypass graft (CABG), dialysis, amputation, retinopathy, and neuropathy) and age at having the 
diagnosis of each complication for the first time .  These variables were defined mainly by ICD-9 
codes or searching parsing notes.   
The response variable was types of DM (i.e., T1DM or T2DM). We ascertained T1DM 
and T2DM cases through these predictors exclusively.  Briefly,  T1DM patients compared to 
T2DM patients were more likely to be diagnosed diabetes at their early ages,  to take insulin 
only, to have DKA or hypoglycemic coma diagnosis, to have other autoimmune–related 
comorbidities, and to have complications occurred earlier (especially have cardiovascular events 
before age of 40 years); T2DM patients compared to T1DM patients were more likely to be 
diagnosed diabetes at their middle ages, to take OHA and/or with insulin, to have complications 
occurred later (especially have cardiovascular events before age of 65 years), and less likely to 
have DKA, hypoglycemic coma diagnosis, or other autoimmune–related comorbidities.  
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Indicators for T1DM cases included (1) in-patient insulin use only; (2) specific ICD 9 code for 
T1DM (250.x1 or 250.x3); (3) parsing notes for T1DM-related diagnosis including childhood-
onset DM, juvenile DM, insulin-dependent DM etc.; (4) DKA diagnosis; (5) hypoglycemia 
diagnosis; (6) other autoimmune-related comorbidities; (7) any complications diagnosis 
(especially before age of 40 years); (8) age; (9) diabetes diagnosis at emergency room or 
inpatient visits.    Indicators for T2DM cases included (1) in-patient use of OHA with or without 
insulin; (2) ICD 9 code for T2DM or unspecified type DM (250.x0 or 250.x2); (3) parsing notes 
for T2DM-related diagnosis including adult DM, non-insulin-dependent diabetes etc.; (4) no 
DKA diagnosis; (5) without hypoglycemic coma diagnosis; (6) no other autoimmune-related 
comorbidities;  (7) with or without other complications (evaluated by ages, e.g., especially 
without after age of 40 years or with after age of 65 years); (8) age.  We considered ICD-9 codes 
diagnosis, medication use, and presence of DKA as relatively stronger indicators and the rest of 
these indicators as ancillary.   
To minimize misclassification between T1DM and T2DM cases, we identified probable, 
possible T1DM and T2DM cases and unknown types of DM cases by using different 
combinations of the above indicators in the MARS dataset.   “Probable” T1DM cases were 
assigned when there are more obvious indicators for T1DM than T2DM, while “probable” 
T2DM cases are with more obvious indicators for T2DM than T1DM.   “Possible” T1DM cases 
were assigned when there are about equally strong indicators for both T1DM and T2DM with 
one or more ancillary indicators for T1DM.  Unknown types of diabetes were assigned to the 
patients when all of the indicators are with missing values or only one or two ancillary indicators 
are not missing.  The clinical detailed algorithms to define these exclusive categories identifying 
probable cases, unknown types of diabetes, and possible cases are presented in the Table 4, 
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Table 5, and Table 6, respectively.    As shown in Table 4, Table 5, and Table 6, we 
designated probable cases as categories 1 to 39, unknown types of diabetic cases as categories 41 
to 53, and possible case as categories 56 to 92.  In total, we identified 126,097 probable cases 
(T1DM: 7,857, T2DM: 118,240), 40,619 possible cases (T1DM: 2,147, T2DM: 38,472), and 
42,926 unknown types of diabetic cases.  We excluded the 42,926 unknown types of diabetic 
cases, and used probable and possible cases to construct the tree models (Figure 2 and Figure 
3). 
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Table 3: Potential Predictors Available in the MARS Dataset 
Variable* Code and definition 
Age Age (years) of patient at first entry into the MARS database 
Gender F= Female, M= Male 
Race 0 = White, 1 = Black, 2= Asian, 3 = Hispanic, 4 = Others 
ICD_DM 1= ICD-9 codes with T1DM specific diagnosis (250.1 or 250.3); 
2= ICD-9 codes with T2DM or unspecified types diagnosis (250.0 or 
250.2); 
3= with both ICD-9 codes for T1DM, and T2DM or unspecified type 
diagnosis ((250.x1 or 250.x3) AND (250.x0 or 250.x2)) 
Missing values = without any ICD-9 codes for DM 
Text_DM1 Identified by parsing notes with T1DM or insulin-dependent diabetes 
mellitus (IDDM), or childhood-onset diabetes 
Text_DM2 Identified by parsing notes with type 2 diabetes or noninsulin-
dependent diabetes mellitus (NIDDM), or adult-onset diabetes 
Insulin With in-patient medication charges of insulin use 
Oralagent With in-patient medication charges include acarbose, acetohexamide, 
chlorpropramide, exenatide, glimepiride, glipizide, glucagon, 
glyburide, metformin, miglitol, nateglinide, pioglitazone, repaglinide, 
rosiglitazone, sitagliptin, tolazamide, tolbutamide, troglitazone 
DKA ICD-9 codes with 250.11 OR 250.13 OR 250.10 OR 250.12 OR 
Text that states DKA (diabetic ketoacidosis) OR Text that states 
Kussmaul respiration OR 
Text that states an odor of acetone on the breath 
Hypo_coma ICD9 codes with 250.31 OR 250.33 OR 250.30 OR 250.32 OR 
text that states hypoglycemic coma 
Thyroid Text that states Grave disease OR Hashimoto’s thyroditis OR 
ICD9 code with 242.X 
Celiac Text that states Celiac disease  OR ICD9 code with 579.0 
Addison Text that states Addison disease  OR ICD9 code with 255.4 
Rubella Text that states congenital rubella infection OR rubella infection OR 
ICD-9 code with 056.XX  
MI ICD-9 code with 410-414 
CABG ICD-9 code with 414.04 
CVE ICD-9 code of MI or CABG (410-414 or 414.04) 
Dialysis ICD-9 code with v45.11 
Amputation ICD-9 code with 89X 
Retinopathy ICD-9 code with 362 
Neuropathy ICD-9 code with 357.2 
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Table 3 continued 
Variable* Code and definition 
Age_MI Age at having the first MI diagnosis 
Age_CABG Age at having the first CABG  
Age_CVE Age at having the first MI or CABG 
Age_Dialysis Age at having the first dialysis diagnosis 
Age_Amputation Age at having the first amputation diagnosis 
Age_Retinopathy Age at having the first retinopathy diagnosis 
Age_Neuropathy Age at having the first neuropathy diagnosis 
Age_Complication Age at having any first complication diagnosis  
ERpt ICD-9 code 250 for emergency room visit 
Inpt ICD-9 code 250 for inpatient visit 
Outpt ICD-9 code 250 for outpatient visit 
Abbreviation: CABG: coronary artery bypass graft; ; CVE: cardiovascular events (including MI and CABG); 
DM: diabetes mellitus; ICD-9 codes: International Classification of Diseases diagnosis codes, version 9; MI: 
myocardial infarction 
*: Except age, age_MI, age_CABG, age_CVE, age_dialysis, age_amputation, age_retinopathy, age_neuropathy 
are continuous variables, the rest of the variables are categorical variable.  Except gender, race, and ICD_DM 
coded differently, the rest of the categorical variables are coded as 1 when patients met the rules or criteria, 
otherwise, coded as 0. 
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Table 4: Defined Clinical Rules to Identify “Probable” Type 1 and Type 2 Diabetic Cases in the MARS Data 
Category ICD_DM¶ Insulin OHA Cofactors¥ Complicationsφ or age at 
having first 
complications 
Age Other factors DM type (n) 
1 1 Yes No     T1DM (1677) 
2 2 No Yes     T2DM (8915) 
3 ≠1 Yes No  Age_comp ≤ 40 ≠ .  T1DM (181) 
4 ≠ 2 No Yes DKA=0 OR hypocoma = 0    T2DM (1850) 
5 ≠ 2 Yes No DKA=1 OR hypocoma = 1  ≠ .  T1DM (653) 
6 ≠ 1 Yes Yes DKA=0 OR hypocoma = 0    T2DM (39714) 
7 1 No No DKA=1 OR hypocoma =1 OR (complication>0 AND 
age_comp≤ 40) 
  T1DM (65) 
8 2 No No DKA=0AND hypocoma=0 Complication = 0 ≥ 65  T2DM (19064) 
9 3 No No DKA=1 OR hypocoma=1 OR (complication>0 AND 
age_comp ≤ 40) 
≠ . Text_T2DM=0 T1DM (83) 
10 2 No No Cofactor=0 Complication = 0 ≠ . Text_T1DM=0 T2DM (22792) 
11 1 No No   ≠ .  T1DM (2273) 
12 2 Yes Yes   ≠ .  T2DM (196) 
13 3 Yes Yes DKA=1 OR hypocoma=1 Complication>0 AND 
age_comp ≤ 40 
 Text_T1DM=1 T1DM (24) 
14 . No No Cofactor = 0 CVE = 0 ≥ 65  T2DM (2982) 
15 . No No DKA =1 OR hypocoma=1 OR (complication>0 AND 
age_comp ≤ 40) 
≠ .  T1DM (26) 
16 2 Yes No DKA=0 AND 
hypocoma=0 
Age_comp ≥ 65  Text_T1DM=0 T2DM (871) 
17 ≠ 2 Yes No   ≠ . , ≤ 40 Text_T2DM=0 T1DM (2209) 
18 3 or . No Yes   ≠ .  T2DM (18) 
19 2 Yes No Cofactor=0 CVE = 0 AND dialysis=0 
AND amputation=0 
>40 Text_T1DM=0 T2DM (14777) 
20 1 Yes Yes Cofactor=0 Complication>0 > 40  T2DM (4) 
21 3 Yes No  CVE = 1 ≠ . Text_T1DM=1 
& 
Text_T2DM=0 
T1DM (33) 
22 3 or . Yes Yes DKA =1 OR hypocoma=1  ≠ . Text_T1DM=1 T1DM (85) 
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Table 4 continued 
Category ICD_DM¶ Insulin OHA Cofactors¥ Complicationsφ or age at 
having first 
complications 
Age Other factors DM type (n) 
23 2 or . No No DKA=0 AND 
hypocoma=0 
 ≠ . Text_T1DM=0 
& 
Text_T2DM=1 
T2DM (206) 
24 2 No No DKA= 0 AND 
hypocoma=0 
Complication=0  Text_T1DM=0 
& 
Text_T2DM=1 
T2DM (330) 
25 1 Yes Yes DKA=1 OR hypocoma=1 OR complication=1 OR ≠ . , ≤ 40 OR 
Text_T1DM=1 
T1DM (29) 
26 Any Any Any  CVE=1 AND age_comp≤ 
40 
≠ .  T1DM (7) 
27 Any No Yes     T2DM (2) 
28 2 Yes No  CVE=1 AND age_comp> 
40 
  T2DM (293) 
29 3 Yes No DKA=1     
30 . Yes No DKA=0 CVE=1 > 40  T2DM (2453) 
31 3 Yes No  CVE=1 ≠ ., <65  T1DM (145) 
32 3 or . Yes Yes DKA=1  >40  T2DM (205) 
33 2 Any Yes DKA=0  ≠ .  T2DM (1533) 
34 3 or . Yes Yes DKA=1  ≠ . , ≤ 40  T1DM (43) 
35 3 No No DKA=1 OR hypocoma=1    T1DM (44) 
36 3 Yes No DKA=0 AND 
hypocoma=0 
Complication=0 ≥ 65  T2DM (1773) 
37 3 Yes No DKA=0 AND 
hypocoma=0 
Complication≥2 And 
age_comp <65 
≠ .  T1DM (51) 
38 3 No No DKA=0 AND 
hypocoma=0 
Complication>0 AND 
age_comp>40 
≠ .  T2DM (147) 
39 . Yes No  CVE=1 ≠ . , ≤ 40  T1DM (1) 
Abbreviation: OHA: oral hypoglycemic agents; age_comp: age at having first complication; age_CVE: age at the first cardiovascular event including 
myocardial infarction (MI) and coronary artery bypass graft (CABG); DKA: diabetic ketoacidosis; ER: ICD-9 code 250 for emergency room diagnosis; 
hypocoma: hypoglycemic coma;  inpt: ICD-9 code 250 for in-patient diagnosis;  outpt: ICD-9 code 250 for out-patient diagnosis;  T1DM: type 1 diabetes 
mellitus; T2DM: type 2 diabetes mellitus; text_T1DM: with any related T1DM diagnosis in the parsing notes; text_T2DM: with any related T2DM diagnosis in 
the parsing notes 
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¶:  ICD_DM: 1= only with ICD-9 code for T1DM specific diagnosis (250.x1 or 250.x3); 2= only with ICD-9 code for T2DM or unspecified type DM diagnosis 
(250.x0 or 250.x2); 3= with both ICD-9 code for T1DM and T2DM or unspecified diagnosis [(250.x1 or 250.x3) AND (250.x0 or 250.x2)]; missing values= 
without any ICD-9 code diagnosis for DM. 
¥: Cofactors include diabetic ketoacidosis (DKA), hypoglycemic coma, thyroid, Addison, and celiac diseases 
φ: Complications include coronary artery bypass graft (CABG), myocardial infarction (MI), dialysis, retinopathy, neuropathy, and  amputations. 
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Table 5: Defined Clinical Rules to Identify “Unknown” Type 1 and Type 2 Diabetic Cases in the MARS Data 
Category ICD_DM¶ Insulin OHA Cofactors¥ Complicationsφ or age at 
having first complications 
Age Other factors DM type (n) 
41 . No No Cofactor=0 Complication=0 = . Er=0 & inpt=0 & 
outpt=0 
DK (2008) 
42 3 No No Cofactor=0 Complication=0 = . Er=0 & inpt=0 & 
outpt=0 
DK (1275) 
43 . Yes No Cofactor=0 Complication=0 = . Er=0 & inpt=0 & 
outpt=0 
DK (820) 
44 . No No Cofactor>0 AND DKA=0 
AND hypo_coma=0 
Complication=0 = . Er=0 & inpt=0 & 
outpt=0 
DK (2) 
45 . No No Cofactor=0 Complication>0 = . Er=0 & inpt=0 & 
outpt=0 
DK (13) 
46 . No No Cofactor=0 Complication=0 ≠ . Er=0 & inpt=0 & 
outpt=0 
DK (52) 
47 . No No Cofactor=0 Complication=0 = . Er=1 & inpt=0 & 
outpt=0 
DK (1698) 
48 . No No Cofactor=0 Complication=0 = . Er=0 & inpt=1 & 
outpt=0 
DK (3988) 
49 . No No Cofactor=0 Complication=0 = . Er=0 & inpt=0 & 
outpt=1 
DK (1190) 
50 . No No DKA=0 AND 
hypo_coma=0 
Complication≥0 = .   DK (12170) 
51 . Yes No Cofactor=0 Complication=0 = .   DK (19190) 
52 3 No No Cofactor=0 Complication=0 = .  DK (594) 
53 . No No (Cofactor>0 OR Complication>0) =.  DK (24) 
Abbreviation: OHA: oral hypoglycemic agents; age_comp: age at having first complication; age_CVE: age at the first cardiovascular event including 
myocardial infarction (MI) and coronary artery bypass graft (CABG); DK: unknown types of diabetes; DKA: diabetic ketoacidosis; ER: ICD-9 code 250 for 
emergency room diagnosis; hypocoma: hypoglycemic coma;  inpt: ICD-9 code 250 for in-patient diagnosis;  outpt: ICD-9 code 250 for out-patient diagnosis;  
T1DM: type 1 diabetes mellitus; T2DM: type 2 diabetes mellitus; text_T1DM: with any related T1DM diagnosis in the parsing notes; text_T2DM: with any 
related T2DM diagnosis in the parsing notes 
¶:  ICD_DM: 1= only with ICD-9 code for T1DM specific diagnosis (250.x1 or 250.x3); 2= only with ICD-9 code for T2DM or unspecified type DM diagnosis 
(250.x0 or 250.x2); 3= with both ICD-9 code for T1DM and T2DM or unspecified diagnosis [(250.x1 or 250.x3) AND (250.x0 or 250.x2)]; missing values= 
without any ICD-9 code diagnosis for DM. 
¥: Cofactors include diabetic ketoacidosis (DKA), hypoglycemic coma, thyroid, Addison, and celiac diseases 
φ: Complications include coronary artery bypass graft (CABG), myocardial infarction (MI), dialysis, retinopathy, neuropathy, and  amputations. 
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Table 6: Defined Clinical Rules to Identify “Possible” Type 1 and Type 2 Diabetic Cases in the MARS Data 
Category ICD_DM¶ Insulin OHA Cofactors¥ Complicationsφ or age at 
having first complications 
Age Other factors DM type (n) 
56 3 Yes Yes DKA=1 CVE=1 & age_CVE > 40 ≠ .  T2DM (13) 
57 3 Yes No  CVE=1 & age_CVE > 40 ≠ .  T2DM (138) 
58 1 Yes Yes DKA=1 OR hypocoma=1  = .  T1DM (1) 
59 1 No No Cofactor>0  = .  T1DM (3) 
60 1 No No Cofactor=0 Complication=0 = . ER=1 OR inpt=1 
OR outpt=1 
T1DM (58) 
61 1 No No Cofactor=0 Complication=0 = . ER=0 & inpt=0 
& oupt=0 
T1DM (125) 
62 1 Yes Yes   = .  T2DM (12) 
63 2 Yes No DKA=1 Age_complication >40 ≠ .  T2DM (15) 
64 2 Yes No Cofactor>0 Complication>0 ≠ .  T2DM (193) 
65 2 No No Cofactor>0  ≠ .  T2DM (71) 
66* 2     = .  T2DM (12014) 
67 3 Yes Yes Cofactor>0  >40  T2DM (185) 
68 3 Yes No Cofactor>0 Complication>0 >40  T1DM (8) 
69 3 Yes No DKA=0 AND hypocoma=0  ≠ . , ≤ 40  T1DM (97) 
70 3 Yes No Cofactor>0 Complication=0 ≠ .  T1DM (21) 
71 3 Yes No Cofactor=0 Complication=0 40<age<65  T2DM (1772) 
72 3 Yes No Cofactor=0 Complication>0 AND 
age_comp>40 
≠ .  T2DM (160) 
73 3 No No DKA=0 AND hypocoma=0 Complication=0 ≠ . , ≤ 30  T1DM (290) 
74 3 No No DKA=0 AND hypocoma=0 Complication=0 ≠ . , > 30  T2DM (2679) 
75 3 Yes Yes DKA=1 OR hypocoma=1 Complication=0 = .  T2DM (61) 
76 3 Yes Yes DKA=1 OR hypocoma=1 Complication>0 = .  T2DM (32) 
77 . Yes Yes DKA=1 OR hypocoma=1  ≠ .  T2DM (9) 
78 . Yes No  Complication=0 ≠ . , ≤ 30  T1DM (24) 
79 . Yes No DKA=0 AND hypocoma=0 Complication=0 ≠ .   T2DM (9720) 
80 . Yes No  Complication>0 ≠ . , >40  T2DM (180) 
81 . No No Cofactor>0 Complication=0 ≠ . , ≤ 30  T1DM (13) 
82 . No No  CVE=1 AND age_CVE>40 ≠ .  T2DM (1111) 
83 . No No  Complication>0 ≠ .  T2DM (26) 
84 . No No DKA=0 AND hypocoma=0 Complication =0 ≠ .  T2DM (3483) 
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Table 6 continued 
Category ICD_DM¶ Insulin OHA Cofactors¥ Complicationsφ or age at 
having first complications 
Age Other factors DM type (n) 
85 . Yes Yes DKA=1 OR hypocoma=1  =. ER=1 OR 
text_T1DM=1 
T1DM (148) 
86 . Yes Yes   = .  T2DM (40) 
87 3 Yes No DKA=0 AND hypocoma=0 Complication>0 = . ER=1 OR 
text_T1DM=1 
T1DM (328) 
88 3 Yes No   = .  T1DM (745) 
89* 3 No No (Cofactor>0 OR complication >0) = .  T2DM (98) 
90 . Yes No DKA=1 OR hypocoma=1  = .  T1DM (291) 
91 . Yes No DKA=0 AND hypocoma=0 Complication=0 = .  T2DM (738) 
92* . Yes No DKA=0 AND hypocoma=0 Complication>0 = .  T2DM (5722) 
 
Abbreviation: OHA: oral hypoglycemic agents; age_comp: age at having first complication; age_CVE: age at the first cardiovascular event including 
myocardial infarction (MI) and coronary artery bypass graft (CABG); DK: unknown types of diabetes; DKA: diabetic ketoacidosis; ER: ICD-9 code 250 for 
emergency room diagnosis; hypocoma: hypoglycemic coma; inpt: ICD-9 code 250 for in-patient diagnosis;  outpt: ICD-9 code 250 for out-patient diagnosis;  
T1DM: type 1 diabetes mellitus; T2DM: type 2 diabetes mellitus; text_T1DM: with any related T1DM diagnosis in the parsing notes; text_T2DM: with any 
related T2DM diagnosis in the parsing notes 
¶:  ICD_DM: 1= only with ICD-9 code for T1DM specific diagnosis (250.x1 or 250.x3); 2= only with ICD-9 code for T2DM or unspecified type DM diagnosis 
(250.x0 or 250.x2); 3= with both ICD-9 code for T1DM and T2DM or unspecified diagnosis [(250.x1 or 250.x3) AND (250.x0 or 250.x2)]; missing values= 
without any ICD-9 code diagnosis for DM. 
¥: Cofactors include diabetic ketoacidosis (DKA), hypoglycemic coma, thyroid, Addison, and celiac diseases 
φ: Complications include coronary artery bypass graft (CABG), myocardial infarction (MI), dialysis, retinopathy, neuropathy, and  amputations. 
55 
 
Figure 2. Obtaining the Final Dataset: Probable and Possible Cases 
 
Figure 3. Obtaining the Final Dataset: Criteria to Distinguish T1DM and T2DM 
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3.4 STATISTICAL ANALYSIS AND DEVELOP TREE-STRUCTURED MODELS 
A wide of variety of software package are available for implementing classification and 
regression trees.  Popular commercial packages include Salford Systems CART, Rulequest’s 
See5, R, TIBCO Spotfire S+, and DTREG, to name a few.  We used the “rpart” functions loaded 
in the Spotfire S+® 8.1 (TIBCO Software Inc.) to construct tree models.     To ensure that we 
developed the best predictable model from the available data, we built tree models for probable 
cases and possible cases, separately.  We also examined the tree models without ICD-9 codes 
diagnosis for T1DM and T2DM.  The tree-model that best served our objectives of simplicity 
and accuracy will be selected as the best model.  The details of the programming codes were 
included in the Appendix A.   
The basis of the decision tree algorithms is the binary recursively partitioning of the data 
into homogenous subsets.  Starting at the tree root, the most discriminative variable is first 
selected to partition the data set into leaf nodes.   The partitioning is repeated until the nodes are 
homogeneous enough to be terminal.  The successive split was chosen such that the binomial 
deviance was minimized, and the nodes became increasingly homogeneous with respect to the 
proportion of individuals who are either T1DM or T2DM.  The “rpart” functions in the S-Plus 
uses 10-fold cross-validation, cost-complexity pruning and surrogate splits.8, 31  The 
classification tree is grown to its maximum size and then pruned on the basis of a criterion that 
balances the number of terminal nodes (complexity) against the accuracy of the tree in 
classifying people, sometimes termed misclassification cost.  Cost-complexity pruning is 
performed to stop generating new split nodes when subsequent splits only result in very little 
overall improvement of the prediction.  This prevents overfitting.  Surrogate splits technique is 
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used to analyze the data of the subjects whose values for any variable are missing.8, 30-31  If the 
primary splitter variable field is missing, a surrogate splitter variable is used instead.    During 
the cross-validation process, all possible combinations of trees were developed using nine of the 
subsets and these were then tested on the 10th subset.   This result provides cross-validation error 
rate, which gives an equitable evaluation of the predictive precision of tree models of different 
sizes.  Using this value, the optimal tree with the minimum error is selected.  We evaluated 
predictive accuracy of the classification trees by using sensitivity, specificity, positive 
predictive value (PPV), and negative predictive value (NPV) of T1DM.  Ultimately, the 
classification rules will be validated internally through randomly chart reviews as our future 
work.  The purpose of the chart review is to obtain an independent ascertainment of a diagnosis 
of T1DM and T2DM.   
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4.0  REASERCH QUESTIONS AND RESULTS 
Among 209,642 diabetic patients with age of 18 years or older, 126,097 probable cases (T1DM: 
7,857 and T2DM: 118,240), 40,619 (T1DM: 2,147 and T2DM: 38,472), and 42,926 patients with 
unknown diabetic type were identified.  The sample consists of 103,502 females (49.37%) and 
97,077 males (46.31%); 160,291 whites (76.46%), 25,433 blacks (12.13%), 335 Asians (0.16%), 
496 Hispanics (0.24%), and 2,009 other races (0.96%).  9,063 (4.32%), 21,080 (10.06%), and 
79,522 (37.93%) patients had missing values in gender, race, and age, respectively.  Table 7 
shows the distribution of probable cases, possible cases, and patients with unknown diabetic 
types by demographic factors, and variables that contribute to identifying T1DM from T2DM.  
T1DM cases were significantly more likely than T2DM cases to be younger (mean ages: 
probable T1DM cases = 44.92, probable T2DM case = 65.00; possible T1DM cases = 27.30, and 
possible T2DM cases = 60.32), to be black, to use insulin, to have ICD-9 codes for T1DM 
diagnosis, to have complications earlier, and to have autoimmune-related comorbidities, to have 
DKA or hypoglycemic coma diagnosis, and to have in-patient, out-patient, or ER diagnosis of 
diabetes.    T2DM cases were more likely than T1DM cases to be older, to be white, to have 
OHA use, and to have complications later.  For each variable related to age, the distribution of 
the individuals with probable and possible T1DM and T2DM cases are displayed in Figure 4.  
The distributions of the various predictors defined by age differ substantially, the lower quartiles 
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of those with T2DM are just below the upper quartile of those with T1DM.  Of all these age-
related variables, “age” appears to be the best single predictor, because all other ages variables 
were calculated from “age”. 
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Table 7: Descriptive Distributions of Each Predictor Variable by Probable, Possible, and Unknown Cases in the MARS dataset 
Variable* Probable T1DM 
(n=7,857) 
Probable T2DM 
(n=118,240) 
Possible T1DM 
(n=2,147) 
Possible T2DM 
(n=38,472) 
Unknown types 
(n=42,926) 
Age at first entry into MARS 
database (years, SD) 
    Missing values (%) 
44.92 (18.91) 
 
433 (5.51) 
65.00 (14.88) 
 
15,799 (13.36) 
27.30 (8.45) 
 
1,699 (79.13) 
60.32 (15.18) 
 
18,717 (48.65) 
47.19 (11.58) 
 
42,874 (99.88) 
Gender 
    Male (%) 
    Female (%) 
    Missing values 
 
4,012 (51.06)  
3,702 (47.12) 
143 (1.82) 
 
56,432 (47.73) 
60,491 (51.16) 
1,317 (1.11) 
 
975 (45.41) 
1108 (51.61) 
64 (2.98)  
 
17,505 (45.50) 
17,841 (46.37) 
3,126 (8.13) 
 
18,153 (42.29) 
20,360 (47.43) 
4,413 (10.28) 
Race (%) 
    White 
    Black 
    Asian 
    Hispanics 
    Other 
    Missing value 
 
5,902 (75.12) 
1,093 (13.91) 
8 (0.10) 
27 (0.34) 
75 (0.95) 
752 (9.52) 
 
93,168 (78.80) 
14,922 (12.62) 
187 (0.16) 
303 (0.26) 
1,214 (1.03) 
8,446 (7.14) 
 
1,528 (71.17) 
466 (21.70) 
3 (0.14) 
6 (0.28) 
20 (0.93) 
124 (5.78) 
 
28,330 (73.64) 
4,318 (11.22) 
69 (0.18) 
74 (0.19) 
329 (0.86) 
5,352 (13.91) 
 
31,363 (73.06) 
4,634 (10.80) 
68 (0.16) 
84 (0.20) 
371 (0.86) 
6,406 (14.92) 
In-patient insulin use (%) 5,361 (68.23) 61,419 (51.94) 1,658 (77.22) 22,645 (58.86) 20,010 (46.62) 
In-patient OHA use (%) 183 (2.33) 50,907 (43.05) 149 (6.94) 417 (1.08) 0 (0.00) 
ICD code (%)¶ 
    T1DM only  
    T2DM or unspecified only    
    Both T1DM and T2DM 
    Missing value 
 
4,044 (51.47) 
30 (0.38) 
1,837 (23.38) 
1,946 (24.77) 
 
261 (0.22) 
95,277 (80.58) 
8,448 (7.14) 
14,254 (12.06) 
 
187 (8.71) 
0 (0.00) 
1,484 (69.12) 
476 (22.17) 
 
12 (0.03) 
12,293 (31.95) 
5,138 (13.36) 
21,029 (54.66) 
 
0 (0.00) 
0 (0.00) 
1771 (4.13) 
41,155 (95.87) 
Age at having first complicationφ in 
MARS database (years, SD) 
48.53 (17.78) 70.52 (11.92) *** 52.5 (9.70) 72.45 (12.13) 
History of CVE (%) 
    CABG 
    MI 
437 (5.56) 
246 (3.13) 
305 (3.88) 
10,006 (8.46) 
6,136 (5.19) 
6,143 (5.20) 
260 (12.11) 
156 (7.27) 
172 (8.20) 
7,565 (19.66) 
4,647 (12.08) 
4,764 (12.38) 
2,558 (5.96) 
1,259 (2.93) 
1,871 (4.36) 
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Table 7 continued 
Variable* Probable T1DM 
(n=7,857) 
Probable T2DM 
(n=118,240) 
Possible T1DM 
(n=2,147) 
Possible T2DM 
(n=38,472) 
Unknown types 
(n=42,926) 
Age at having first CVE (years, SD) 
    CABG 
    MI 
53.92 (14.28) 
57.07 (13.83) 
52.03 (14.01) 
71.71 (11.32) 
72.33 (10.38) 
71.16 (11.92) 
*** 
*** 
*** 
*** 
*** 
*** 
74.98 (10.98) 
74.98 (9.75) 
*** 
History of dialysis (%) 171 (2.18) 594 (0.50) 65 (3.03) 778 (2.02) 211 (0.49) 
Age at having first dialysis (years, 
SD) 
42.98 (13.69) 66.53 (13.14) 52.5 (9.19) 65.44 (12.95) *** 
History of amputation (%) 73 (0.93) 478 (0.40) 45 (2.10) 350 (0.91) 114 (0.27) 
Age at having first amputation (years, 
SD) 
48.05 (17.03) 68.60 (12.61) *** 48.00 (7.00) 67.52 (13.00) 
History of retinopathy (%) 295 (3.75) 868 (0.73) 330 (0.86) 163 (7.59) 17 (0.04) 
Age at having first retinopathy (years, 
SD) 
49.63 (13.03) 65.76 (11.89) *** 68.84 (10.37) *** 
History of neuropathy (%) 397 (5.05) 2,976 (2.52) 293 (13.65) 716 (1.86) 24 (0.06) 
Age at having first neuropathy (years, 
SD) 
50.14 (12.84) 66.97 (12.51) 55.2 (11.90) 67.19 (11.78) *** 
History of DKA (%) 1,414 (18.00) 254 (0.21) 426 (19.84) 726 (1.86) 23 (0.05) 
History of hypoglycemic coma (%) 740 (9.42) 170 (0.14) 148 (6.89) 81 (0.21) 8 (0.02) 
History of thyroid disease (%) 53 (0.67) 566 (0.48) 45 (2.10) 786 (2.04) 338 (0.79) 
History of celiac disease (%) 22 (0.28) 63 (0.05) 12 (0.56) 96 (0.25) 28 (0.07) 
History of Addison disease (%) 66 (0.84) 313 (0.26) 35 (1.63) 951 (2.47) 153 (0.36) 
With in-patient-DM diagnosis (%) 5,144 (65.47) 77,512 (65.55) 1,520 (70.80) 27,214 (70.74) 33,291 (77.55) 
With out-patient-DM diagnosis (%) 1,292 (16.44) 11,241 (9.51) 609 (28.37) 8438 (21.93) 13,065 (30.44) 
With ER-DM diagnosis (%) 2,826 (35.97) 37,943 (32.09) 1,288 (59.99) 15,153 (39.39) 18,211 (42.42) 
Abbreviation: OHA: oral hypoglycemic agents; CABG: coronary artery bypass graft; CVE: cardiovascular events including myocardial infarction (MI) and 
coronary artery bypass graft (CABG); DKA: diabetic ketoacidosis; ER: emergency room; MI: myocardial infarction; T1DM: type 1 diabetes mellitus; T2DM: 
type 2 diabetes mellitus 
*: All the variables are significantly different cross different groups. 
***: All of the patients in these groups are with missing values in age or only one case with age value. 
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¶:  ICD_DM: T1DM only= only with ICD-9 code for T1DM specific diagnosis (250.x1 or 250.x3); T2DM or unspecified only= only with ICD-9 code for 
T2DM or unspecified type DM diagnosis (250.x0 or 250.x2); Both T1DM and T2DM= with both ICD-9 code for T1DM and T2DM or unspecified diagnosis 
[(250.x1 or 250.x3) AND (250.x0 or 250.x2)]; missing values= without any ICD-9 code diagnosis for DM. 
φ: Complications include coronary artery bypass graft (CABG), myocardial infarction (MI), dialysis, retinopathy, neuropathy, and  amputations.
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Figure 4. Box Plots of the Age-Related Variables in the MARS data. 
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4.1 WHAT ARE THE MAIN CHARACTERISTICS TO DISTINGUISH T1DM AND 
T2DM? 
Constructing a good classifier whose performance will stand up under cross-validation and that 
is useful and practical is our first priority.  All the predictors available in the MARS data (Table 
3) were used in the estimation.   In this section, we describe the results from the default tree 
models briefly and further addressed results shown in the pruned trees in more detail.  For the 
“probable cases”, Figure 5 presents the default tree-based model whereby successive partitions 
of the data into homogenous subsets are shown with the rule labeling each split.  This form of 
tree display is primarily for presentation purpose, as it conceals the details of the tree-growing 
process.  The numbers under each terminal node are the observations of T1DM and T2DM, 
separately; for example, in the leftmost terminal node in the Figure 5, which labeled T1DM, 
4,015 patients were actually probable T1DM cases and 0 patients were actually probable T2DM 
cases.  The predictors selected in the default tree model were ICD codes for DM diagnosis, OHA 
use, history of DKA diagnosis, in-patient insulin use, age of 40.5 years, duration in the MARS 
database, and in-patient diagnosis of DM.  The algorithm underlying tree-based prediction 
determines the cutoff point of age more objectively (by optimization) as 40.5 years.  The result 
of repeated “recursive partitioning” also leads to the tree displayed in the Table 8.  The 
semigraphical representation is different from those used in Figure 5.  It is most useful when the 
details of the fitting procedure are of interest.  In the Table 8, the first number after the split is 
the number of observations, the second number is the loss number from target category, and the 
third number is the predicted target category.  The “yprob” gives the probabilities of T1DM and 
T2DM individually in each node.   
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Note that the tree has not been pruned to the final size yet.  The pruning of the 
classification tree in “rpart” defaults impurity criterion the Gini index.  The pruining criterion 
is the predicted loss, or normally called error rate.  We then pruned the default tree to an 
optimally sized tree based on the cross-validation results in the Table 9 and Figure 6.  In Table 
9, the columns xerror and xstd are random, depending on the random partition used in the 10-
fold cross-validation that has been computed within “rpart”.  The table is printed from the 
smallest tree (no splits) to the largest one.  The number of splits is listed, rather than the number 
of nodes.  The number of nodes is always 1 plus the number of splits.    For easier reading, the 
error columns have been scaled so that the first node has an error of 1.  All the errors are the 
proportions of the error for the root tree. In Table 9, the model with no splits must make 
7,860/126,097 misclassifications, multiply columns 3 by 7,860 to get a results in terms of 
absolute error (computations are done on the absolute error scale, and printed on relative scale).  
The complexity parameter (cp) may then be chosen to minimize xerror.  A practical procedure 
is to use the 1-SE rule; i.e., pick up the value no larger than minimum xerror within one standard 
deviation.  In Table 9, the 1-SE rule gives 0.157+0.00445, so we chose the line 6, a tree with 7 
splits and 8 terminal nodes.  This is easier to see graphically in Figure 6, where we take the 
leftmost pruning point with value below the line.   
Now, we explain the pruned tree explicitly (Figure 7 and Table 10).  The split on 
“ICD.DMtype” (i.e., if ICD.DM type=1, go to the left node; if ICD.DMtype = 2 or 3 or missing, 
go to the right node) partitions the 126,097 observations into group of 4,305 and 121,792 
individuals (nodes 2 and 3), with the probability of T1DM of 0.93937 and 0.03130, respectively.   
The first group is then partitioned into groups of 4,015 and 290 individuals (nodes 4 and 5), 
depending on whether they use OHA or not. The former group, with probability of T1DM of 1.0, 
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is not subdivided further.  The latter group, with probability of T1DM of 0.1 (i.e., probability of 
T2DM of 0.9), is also a terminal node.   The group of the node 3 is subdivided into group of 
1,399 and 120,393 individuals (nodes 6 and 7), depending on whether or not having a DKA 
diagnosis.  The retrospective probabilities of T1DM for these groups are 0.81844 and 0.02216.  
The group of the node 6 is subdivided into group of 1,146 and 253 individuals (nodes 12 and 13), 
depending on ICD codes for DM (i.e., if ICD.DM type=3, go to the left node; if ICD.DMtype = 
2 or missing, go to right node).  Both of the groups are terminal nodes.  The probabilities of 
T1DM are 0.98778 and 0.05138 in the former and latter groups, separately. The group of the 
node 7 is partitioned into group of 8,757 and 111,636 individuals (nodes 14 and 15); depending 
on age at first entry into the MARS database is < 40.5 or ≥ 40.5 years.   The latter group, with 
probability of T1DM of 0.00236 (i.e., probability of T2DM of 0.99764), is not subdivided 
further.   The former group continued partitioning process based on in-patient insulin and OHA 
use.  This procedure continues, yielding 8 distinct probabilities of T1DM ranging from 0 to 1.  
Clearly, as the partitioning continues, our trust in the individual estimated probabilities decreases 
as they are based on less and less data.    
Considering ICD-9 codes for T1DM or T2DM as a strong predictor presumably, we 
evaluated the tree model leaving the variable “ICD.DMtype” out of the formula.  In Figure 8 
and Table 9, the pruned tree is as same as the full-sized tree since selected cp is 0.01 as same as 
the default of cp in the “rpart”.  The predictors selected in the pruned tree model were age of 
40.5 years, insulin use, history of DKA diagnosis and OHA use.   Obviously, it became more 
heterogeneous in the terminal nodes labeled as T1DM with probabilities of T2DM from 0 to 
0.25.         
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For the “possible cases”, Figure 9 and Table 12 present the default tree-based model.  
Selected predictors include ICD codes for DM diagnosis, age of 30.5 years, history of DKA 
diagnosis, history of hypoglycemic coma, in-patient insulin use, in-patient OHA use, age of 40.5 
years, duration in the MARS database, and numbers of complications recorded.  The overplotting 
of labels is a common occurrence with this type of display when the tree is big with many splits.  
Then, we chose the pruned tree in size of 12 based on cross-validation results in the Table 13 
and Figure 10.  In Table 9, we selected 0.644+0.0170 based on the 1-SE rule.  We also can take 
the leftmost pruning point with value below the line shown in Figure 10.  The pruned tree is 
exactly equal to the original default tree (Figure 11 and Table 12).  The split on “ICD.DMtype” 
(i.e., if ICD.DM type=1 or 3, go to the left node; if ICD.DMtype = 2 or missing, go to the right 
node) partitions the 40,619 observations into group of 7,018 and 33,601 individuals (nodes 2 and 
3), with the probability of T1DM of 0.25919 and 0.00976, respectively.   The first group is then 
partitioned into groups of 315 and 6,703 individuals (nodes 4 and 5), depending on whether age 
< 30.5 or ≥ 30.5 years.  The former group, with probability of T1DM of 1.0, is not subdivided 
further.  The group of node 5 continued subdivided into group of 3,740 and 2,963 individuals 
(nodes 10 and 11), depending on whether or not having insulin use.  The retrospective 
probabilities of T1DM for these groups are 0.35241 and 0.06277.  The group of the node 10 is 
subdivided into group of 69 and 3,671 individuals (nodes 20 and 21), depending on age <40.5 or 
≥ 40.5 years.  The former group became a terminal node with T1DM probability of 1.0.  The 
latter group further partitioned into the groups of 2,188 and 1,483 depending on their duration in 
the MARS database less or longer than 1468.5 days (about 4 years).  The latter group is a 
terminal node with the probability of T1DM of 0.19218.  The group of the node 42 is further 
subdivided according to the durations in the MARS database (less or longer than 2672.5 days, or 
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about 7 years), in-patient OHA use and numbers of complications occurred.  The group of node 3 
continued subdivided into group of 633 and 32,938 individuals (nodes 6 and 7), depending on 
whether or not having DKA diagnosis.  The latter group became a terminal node with the 
probability 0.00154 of T1DM. The group of the node 6 is partitioned into group of 108 and 555 
individuals (nodes 12 and 13) based on having hypoglycemic coma or not.  Both of them became 
terminal nodes with the predicted probabilities of T1DM being 0.96296 and 0.31171.  This 
procedure yielding 12 distinct probabilities of T1DM ranging from 0 to 1.  Clearly, as the 
partitioning continues, our trust in the individual estimated probabilities decreases as they are 
based on less and less data.   The heterogeneity became more obvious in the nodes with smaller 
splits.  Similarly, in Figure 8 and Table 9, the pruned tree without considering ICD-9 code as a 
predictor in the model selected age of 30.5 years, in-patient diagnosis of DM, duration in the 
MARS database, in-patient insulin use, history of DKA diagnosis, history of hypoglycemic 
coma, and in-patient OHA use.   Compared with the pruned tree with ICD-9 code as a predictor, 
it became more heterogeneous in the terminal nodes labeled as T1DM with probabilities of 
T2DM from 0.02 to 0.33.   
In summary, the main characteristics to distinguish T1DM and T2DM include ICD-9 
codes for T1DM and T2DM, in-patient insulin use, in-patient OHA use, history of DKA 
diagnosis, and age of 40.5 years across all of the pruned tree-based models.   History of 
hypoglycemic coma, duration in the MARS database, number of complications, and an-inpatient-
diagnosis of DM may be considered as ancillary factors to predict T1DM cases.  
69 
 
Figure 5. A Default Tree-Based Model for Predicting “Probable” T1DM and T2DM Cases 
 
Table 8: A Default Tree-Based Model for Predicting “Probable” T1DM and T2DM Cases 
node), split, n, loss, yval, (yprob)             * denotes terminal node 
1) root 126097 7857 T2DM (0.06230 0.93769)   
    2) ICD.DMtype=1 4305  261 T1DM (0.93937 0.06062)   
      4) oralagent=0 4015    0 T1DM (1.00000 0.00000) * 
      5) oralagent=1 290   29 T2DM (0.10000 0.90000) * 
    3) ICD.DMtype=2,3 121792 3813 T2DM (0.03130 0.96869)   
      6) DKA=1 1399  254 T1DM (0.81844 0.18156)   
       12) ICD.DMtype=3 1146   14 T1DM (0.98778 0.01221) * 
       13) ICD.DMtype=2 253   13 T2DM (0.05138 0.94862) * 
      7) DKA=0 120393 2668 T2DM (0.02216 0.97784)   
       14) Age< 40.5 8757 2404 T2DM (0.27452 0.72548)   
         28) insulin=1 4169 1802 T1DM (0.56776 0.43224)   
           56) oralagent=0 3206  839 T1DM (0.73830 0.26170)   
            112) ICD.DMtype=3 1020    0 T1DM (1.00000 0.00000) * 
            113) ICD.DMtype=2 2186  839 T1DM (0.61619 0.38381)   
              226) dur.MARS< 1183.5 1967  628 T1DM (0.68073 0.31927)   
                452) inpt=1 1710  427 T1DM (0.75029 0.24971) * 
                453) inpt=0 257   56 T2DM (0.21790 0.78210) * 
              227) dur.MARS>=1183.5 219    8 T2DM (0.03653 0.96347) * 
           57) oralagent=1 963    0 T2DM (0.00000 1.00000) * 
         29) insulin=0 4588   37 T2DM (0.00806 0.99194) * 
       15) Age>=40.5 111636  264 T2DM (0.00236 0.99764) *  
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Table 9: Complexity Parameters from Cross-validations for Predicting “Probable” T1DM and T2DM Cases  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Complexity Parameter Plot for Predicting “Probable” T1DM and T2DM Cases 
 
 
 
Classification tree: 
rpart(formula = DM ~ sex + race2 + Age + ICD.DMtype + insulin + oralagent + inpt + outpt + er + DKA + 
Hypo.Coma + CVE + dialysis + retinopathy + neuropathy + amputation + thyroid + celiac + addison + dur.MARS + 
Age.CVE + Age.neuropathy + Age.retinopathy + Age.dialysis + Age.amputation + Age.complication + 
count.cofactor + count.complication, data = mars.031010.dm12.probable, method = "class") 
Variables actually used in tree construction: 
[1] Age        DKA        ICD.DMtype dur.MARS   inpt       insulin    oralagent  
Root node error: 7860/126097 = 0.0623; n= 126097  
      CP nsplit rel error  xerror xstd  
1  0.4815     0      1.000   1.000  0.01092 
2  0.1134     1      0.519   0.519  0.00799 
3  0.0648     2      0.405   0.405  0.00709 
4  0.0295     5      0.211   0.211  0.00514 
5  0.0289     6     0.181   0.193  0.00493 
7  0.0100    10      0.108   0.169  0.00462 
6  0.0129     7      0.152   0.157  0.00445 
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Figure 7. A Pruned Tree for Predicting “Probable” T1DM and T2DM Cases 
 
Table 10: A Pruned Tree-based Model for Predicting “Probable” T1DM and T2DM Cases 
node), split, n, loss, yval, (yprob)             * denotes terminal node 
1) root 126097 7857 T2DM (0.06230 0.93769)   
   2) ICD.DMtype=1 4305  261 T1DM (0.93937 0.06062)   
     4) oralagent=0 4015    0 T1DM (1.00000 0.00000) * 
     5) oralagent=1 290   29 T2DM (0.10000 0.90000) * 
   3) ICD.DMtype=2,3 121792 3813 T2DM (0.03130 0.96869)   
     6) DKA=1 1399  254 T1DM (0.81844 0.18156)   
      12) ICD.DMtype=3 1146   14 T1DM (0.98778 0.01221) * 
      13) ICD.DMtype=2 253   13 T2DM (0.05138 0.94862) * 
     7) DKA=0 120393 2668 T2DM (0.02216 0.97784)   
      14) Age< 40.5 8757 2404 T2DM (0.27452 0.72548)   
        28) insulin=1 4169 1802 T1DM (0.56776 0.43224)   
          56) oralagent=0 3206  839 T1DM (0.73830 0.26170) * 
          57) oralagent=1 963    0 T2DM (0.00000 1.00000) * 
        29) insulin=0 4588   37 T2DM (0.00806 0.99194) * 
      15) Age>=40.5 111636  264 T2DM (0.00236 0.99764) * 
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Figure 8. A Pruned Tree for Predicting “Probable” T1DM and T2DM Cases: Without ICD Codes in the Formula 
 
 
Table 11: A Pruned Tree-Based Model and Complexity Parameters for Predicting “Probable” T1DM and 
T2DM Cases: Without ICD codes in the Formula 
A pruned tree model Complexity parameters and errors 
n= 126097  
node), split, n, loss, yval, (yprob) 
      * denotes terminal node 
 1) root 126097 7857 T2DM (0.06230 0.93769)   
   2) Age< 40.5 10446 4050 T2DM (0.38771 0.61229)   
     4) insulin=1 5169 1833 T1DM (0.64539 0.35461)   
       8) oralagent=0 4063  839 T1DM (0.79350 0.20650) * 
       9) oralagent=1 1106  112 T2DM (0.10127 0.89873) * 
     5) insulin=0 5277  714 T2DM (0.13530 0.86470) * 
   3) Age>=40.5 115651 3807 T2DM (0.03291 0.96708)   
     6) DKA=1 884  218 T1DM (0.75339 0.24661)   
      12) oralagent=0 601    0 T1DM (1.00000 0.00000) * 
      13) oralagent=1 283   65 T2DM (0.22968 0.77032) * 
     7) DKA=0 114767 3141 T2DM (0.02736 0.97263) * 
Variables actually used in tree construction: 
[1] Age       DKA       insulin   oralagent  
 
Root node error: 7860/126097 = 0.0623 
 
n= 126097 
  
      CP nsplit rel error xerror    xstd  
1 0.0956      0     1.000  1.000 0.01092 
2 0.0570      3     0.696  0.696 0.00921 
3 0.0195      4     0.639  0.639 0.00884 
4 0.0100      5     0.620  0.620 0.00871  
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Figure 9. A Default tree-Based Model for Predicting “Possible” T1DM and T2DM Cases 
 
Table 12: A Full and Pruned Tree-Based Model for Predicting “Possible” T1DM and T2DM Cases 
node), split, n, loss
      * denotes terminal node 
, yval, (yprob) 
1) root 40619 2147 pT2DM (0.05285 0.94714 
2) ICD.DMtype=1,3 7018 1819 pT2DM (0.25919 0.74081)   
      4) Age< 30.5 315    0 pT1DM (1.00000 0.00000) * 
      5) Age>=30.5 6703 1504 pT2DM (0.22438 0.77562)   
       10) insulin=1 3740 1318 pT2DM (0.35241 0.64759)   
         20) Age< 40.5 69    0 pT1DM (1.00000 0.00000) * 
         21) Age>=40.5 3671 1249 pT2DM (0.34023 0.65977)   
           42) dur.MARS>=1468.5 2188  964 pT2DM (0.44059 0.55941)   
             84) dur.MARS>=2672.5 928  438 pT1DM (0.52802 0.47198)   
              168) oralagent=0 789  336 pT1DM (0.57414 0.42586) * 
              169) oralagent=1 139   37 pT2DM (0.26619 0.73381) * 
             85) dur.MARS< 2672.5 1260  474 pT2DM (0.37619 0.62381)   
              170) count.complication>=0.5 305  140 pT1DM (0.54098 0.45902) * 
              171) count.complication< 0.5 955  309 pT2DM (0.32356 0.67644) * 
           43) dur.MARS< 1468.5 1483  285 pT2DM (0.19218 0.80782) * 
       11) insulin=0 2963  186 pT2DM (0.06277 0.93723)   
         22) ICD.DMtype=1 186    0 pT1DM (1.00000 0.00000) * 
         23) ICD.DMtype=3 2777    0 pT2DM (0.00000 1.00000) * 
    3) ICD.DMtype=2 33601  328 pT2DM (0.00976 0.99024)   
      6) DKA=1 663  277 pT2DM (0.41780 0.58220)   
       12) Hypo.Coma=1 108    4 pT1DM (0.96296 0.03703) * 
       13) Hypo.Coma=0 555  173 pT2DM (0.31171 0.68829) * 
      7) DKA=0 32938   51 pT2DM (0.00154 0.99845) *  
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Table 13: Complexity Parameters from Cross-Validations for Predicting “Possible” T1DM and T2DM Cases  
Figure 10. Complexity Parameter Plot for Predicting “Possible” T1DM and T2DM Cases 
 
 
Classification tree: 
rpart(formula = DM ~ sex + race2 + Age + ICD.DMtype + insulin + oralagent + inpt + outpt + er + DKA + 
Hypo.Coma + CVE + dialysis + retinopathy + neuropathy + amputation + thyroid + celiac + addison + dur.MARS + 
Age.CVE + Age.neuropathy + Age.retinopathy + Age.dialysis + Age.amputation + Age.complication + 
count.cofactor + count.complication, data = mars.031010.dm12.possible, method = "class") 
 
Variables actually used in tree construction: 
[1] Age   DKA  Hypo.Coma  ICD.DMtype  count.complication dur.MARS  insulin   oralagent       
    
Root node error: 2150/40619 = 0.0529;  n= 40619  
 
      CP  nsplit    rel error  xerror  xstd  
1 0.0734      0     1.000  1.000 0.0210 
2 0.0433      2     0.853 0.853 0.0195 
3 0.0321      4     0.767 0.767 0.0185 
4  0.0233      5     0.735 0.735 0.0181 
5  0.0182      7     0.688 0.677 0.0174 
6  0.0116     10     0.633 0.670 0.0174 
7  0.0100     11     0.622 0.644 0.0170  
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Figure 11. A Pruned Tree for Predicting “Possible” T1DM and T2DM Cases 
Figure 12.  A Pruned Tree for Predicting “Possible” T1DM and T2DM Cases: Without ICD Codes in the 
Formula  
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Table 14: A Pruned Tree-Based Model and Complexity Parameters for Predicting “Possible” T1DM and 
T2DM Cases: Without ICD Codes in the Formula 
A pruned tree model Complexity parameters and errors 
node), split, n, loss
      * denotes terminal node 
, yval, (yprob) 
 1) root 40619 2147 pT2DM (0.052857 0.94714 )   
   2) Age< 30.5 894  352 pT2DM (0.39374  0.60626 )   
     4) inpt=0 402  119 pT1DM (0.70398  0.29602 )   
       8) dur.MARS>=3.5 350   68 pT1DM (0.80571  0.19429 ) * 
       9) dur.MARS< 3.5 52    1 pT2DM (0.019231 0.98077 ) * 
     5) inpt=1 492   69 pT2DM (0.14024  0.85976 )   
      10) insulin=1 61   14 pT1DM (0.77049  0.22951 ) * 
      11) insulin=0 431   22 pT2DM (0.051044 0.94896 ) * 
   3) Age>=30.5 39725 1795 pT2DM (0.045186 0.95481 )   
     6) DKA=1 1135  426 pT2DM (0.37533  0.62467 )   
      12) Hypo.Coma=1 201   67 pT1DM (0.66667  0.33333 )   
        24) oralagent=0 106    2 pT1DM (0.98113  0.018868) * 
        25) oralagent=1 95   30 pT2DM (0.31579  0.68421 ) * 
      13) Hypo.Coma=0 934  292 pT2DM (0.31263  0.68737 ) * 
     7) DKA=0 38590 1369 pT2DM (0.035476 0.96452 ) * 
 
Variables actually used in tree construction: 
[1] Age  DKA    Hypo.Coma dur.MARS  
inpt      insulin   oralagent  
 
Root node error: 2150/40619 = 0.0529 
 
n= 40619  
 
      CP nsplit rel error xerror   xstd  
1 0.0382      0     1.000  1.000 0.0210 
2 0.0233      2     0.924  0.924 0.0202 
3 0.0156      3     0.900  0.902 0.0200 
4 0.0154      6     0.853  0.879 0.0198 
 
5 0.0100      7     0.837  0.839 0.0193  
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4.2 HOW WELL THE TREE-STRUCTURED MODELS CAN DISTINGUISH T1DM 
FROM T2DM? WHAT IS THE MISCLASSIFICATION RATE, SENSITIVITY, 
SPECIFICITY, POSITIVE PREDICTIVE VALUE (PPV), NEGATIVE PREDICTIVE 
VALUE (NPV) OF T1DM CASES? 
Considering T1DM as the truth (i.e., positive category) and T2DM as a negative category, we 
calculated misclassification rates, sensitivity, specificity, PPV and PNV of T1DM cases for each 
final tree-based model (Table 15 and Table 16).  As shown in Table 15, the tree model using 
probable identified cases has the highest sensitivity (default tree: 94.82%; pruned tree: 95.63%), 
specificity (default tree: 99.63%; pruned tree: 99.28%), PPV (default tree: 94.41%; pruned tree: 
89.81%) and PNV (default tree: 99.60%; pruned tree: 99.71%).   The tree model using possible 
identified cases has the lowest sensitivity of 60.18%, specificity of 98.75%, PPV of 72.91% and 
PNV of 97.80%, even though the tree is bigger and with more variables to split the observations.   
The misclassification rate of T1DM cases as T2DM cases increases from 4.37% to 39.82% while 
we used possible cases instead of probable cases.   In total, 37,705 (22.62%) probable and 
possible cases had missing ICD-9 codes.  As we expected, all of the models lost the accuracy 
when we removed ICD-9 codes diagnosis from the model (Table 16).  The misclassification rate 
of T1DM as T2DM cases was almost 80% in the possible cases.  The sensitivity of T1DM was 
dropped greatly from 48.68% to 20.17%.   
Compared the default tree model with the pruned tree model using probable cases, we 
can see the predictors “duration of MARS” and “in-patient diagnosis of DM” increase the PPV 
of T1DM.  However, they do not improve the misclassification rate and sensitivity of T1DM.  
The specificity and NPV of T1DM are about the same.  Considering the predictor “duration of 
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MARS” which reflects the duration of follow-up in the MAR database may not be generalizable 
to other administrative date, either the default tree model without “duration of MARS” or pruned 
tree model using probable cases can be the predictive rules to distinguish T1DM from T2DM.  
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Table 15: Summary Results: Predictive Trees of Probable and  Possible T1DM and T2DM Cases 
 Probable Cases 
(Default tree) 
Probable Cases 
(Pruned tree) 
Possible Cases 
Actual cases (T1DM/T2DM) 7,857 / 118,240 7,857 / 118,240 2,147 / 38,472 
Predicted cases (T1DM/T2DM) 7,891 / 118,206 8,367 / 117,730 1,772 / 38,847 
Size of the tree (no. of terminal 
nodes) 
11 8 12 
Variable selected ICD_DM¶ 
In-patient OHA use 
In-patient insulin use 
DKA 
Age 
Duration in MARS 
In-patient diagnosis 
ICD_DM¶ 
In-patient OHA use 
In-patient insulin use 
DKA 
Age 
ICD_DM¶ 
In-patient OHA use 
In-patient insulin use 
DKA 
Hypocoma 
Age 
Duration in MARS  
No of complicationsφ 
Misclassification rate of T1DM 
(%) 
5.18 4.37 39.82 
Misclassification rate of T2DM 
(%) 
0.37 0.72 1.25 
Sensitivity of T1DM (%) 94.82 95.63 60.18 
Specificity of T1DM (%) 99.63 99.28 98.75 
PPV of T1DM (%) 94.41 89.87 72.91 
NPV of T1DM (%) 99.60 99.71 97.80 
Abbreviation: OHA: oral hypoglycemic agents; DK: unknown types of diabetes; DKA: diabetic ketoacidosis; 
hypocoma: hypoglycemic coma; T1DM: type 1 diabetes mellitus; T2DM: type 2 diabetes mellitus;  
¶:  ICD_DM: 1= only with ICD-9 code for T1DM specific diagnosis (250.x1 or 250.x3); 2= only with ICD-9 code 
for T2DM or unspecified type DM diagnosis (250.x0 or 250.x2); 3= with both ICD-9 code for T1DM and T2DM or 
unspecified diagnosis [(250.x1 or 250.x3) AND (250.x0 or 250.x2)]; missing values= without any ICD-9 code 
diagnosis for DM. 
φ: Complications include coronary artery bypass graft (CABG), myocardial infarction (MI), dialysis, retinopathy, 
neuropathy, and  amputations. 
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Table 16: Summary Results: Final Predictive Trees of Probable and Possible T1DM and T2DM Cases: 
Without ICD Codes¶ in the Formula 
 Probable Cases Possible Cases 
Actual cases (T1DM/T2DM) 7,857 / 118,240 2,147 / 38,472 
Predicted cases (T1DM/T2DM) 4,664 / 121,433 517 / 40,102 
Size of the tree (no. of terminal nodes) 6 8 
Variable selected Age  
OHA 
Insulin 
DKA 
 
Age 
OHA 
Insulin 
DKA 
Hypocoma 
Duration in MARS  
Inpt 
Misclassification rate of T1DM (%) 51.32 79.83 
Misclassification rate of T2DM (%) 0.71 0.22 
Sensitivity of T1DM (%) 48.68 20.17 
Specificity of T1DM (%) 99.29 99.78 
PPV of T1DM (%) 82.01 83.75 
NPV of T1DM (%) 96.68 95.73 
Abbreviation: OHA: oral hypoglycemic agents; DK: unknown types of diabetes; DKA: diabetic ketoacidosis; ER: 
ICD-9 code 250 for emergency room diagnosis; hypocoma: hypoglycemic coma; inpt: ICD-9 code 250 for in-
patient diagnosis;  T1DM: type 1 diabetes mellitus; T2DM: type 2 diabetes mellitus;  
¶:  ICD_DM: 1= only with ICD-9 code for T1DM specific diagnosis (250.x1 or 250.x3); 2= only with ICD-9 code 
for T2DM or unspecified type DM diagnosis (250.x0 or 250.x2); 3= with both ICD-9 code for T1DM and T2DM or 
unspecified diagnosis [(250.x1 or 250.x3) AND (250.x0 or 250.x2)]; missing values= without any ICD-9 code 
diagnosis for DM. 
 
 
81 
 
5.0  DISCUSSION 
We have developed a tree-structured model to help distinguish people with T1DM or T2DM.  
ICD-9 codes of T1DM or T2DM, history of DKA, age of 40, in-patient insulin use, and in-
patient OHA use are consistent predictors in the tree models to distinguish T1DM from T2DM 
cases.  Other ancillary predictors may include in-patient diagnosis of DM, history of 
hypoglycemic coma, episodes of complications including MI, CABG, dialysis, retinopathy, 
neuropathy and amputation, and duration in the MARS database.  The sensitivity, specificity, 
PPV, and NPV of the default tree to predict T1DM are 94.82%, 99.63%, 94.41% and 99.60% 
among the probable diabetic cases.  To the best of our knowledge, there are no other tools or 
studies designed to distinguish between T1DM or T2DM using a large administrative/clinical 
database.  Default tree without “duration of MARS” which is not dependent on one insurer or 
other specific population may be more applicable to another general diabetic population.   Either 
the default or pruned tree can be used to identify a cohort of T2DM well. 
Administrative data poses some challenges in statistical analysis.  It often involves 
complex interactions between explanatory variables.  Missing values for both explanatory and 
outcome variables are fairly common, and outliers usually exist.  The high levels of missing 
predictor information in our clinically derived data would be considered a serious limitation in 
epidemiological analyses.  Thus, a tree-structured model provides some advantages of handling a 
82 
 
large administrative data.  (1) Using surrogate splits as the treatment of missing values (as NAs 
in the tree dataset) is more satisfactory compared to the linear or logistic regression model. (2) It 
naturally handles non-homogeneous or nonlinear relationships.  (3) It also does automatic 
stepwise variable selection and complexity reduction.  (4) It is invariant to monotone 
transformations of predictor variables so that the precise form in which these appear in a model 
formula is irrelevant.  (5) It is robust with respect to outliers and misclassified points in the 
learning sample.  (6) The tree structure gives easily understood and provides intuitive 
information regarding the predictive structure of the data.  Traditional linear or logistic 
regression models do allow for the testing of statistical interactions among independent 
variables, which assess differences in the effects of one or more independent variable according 
to levels of another independent variable.  However, statistical interactions can be difficult to 
interpret and to identify, particularly when three or more variables are assessed at a time.35  (7) 
The final classification has a simple form that can be compactly stored and used efficiently to 
classify new data.   
Nevertheless, there are some problems inherent in the tree procedure.  Tree stability is 
sometimes a concern.  It is not necessarily stable to small perturbations in the data.   Splits that 
tend to separate a node into one small and one large subset (also called “end cuts”), while all 
other things are equal and favored over “middle cut”.  Also, variable selection is biased in favor 
of those variables having more values and thus offering more splits.  Ideally, a reliable predictive 
factor or model has a high sensitivity to detect most patients who are destined to have outcome 
and a specificity that results in a low false-positive rate and the correct identification of most 
patients who will have the outcome.  A factor is adequately predictive based not only on the 
magnitude of the relative risk but also on the prevalence of both of the factor and the outcome.  
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A risk factor that has a strong association with a clinical outcome may not be good predictor if its 
prevalence and the prevalence of the outcome are extremely low.36  That is probably the reason 
why some expected factors were not identify in our tree-model, such as cardiovascular 
complications. 
We also acknowledge some limitations inherent in the MARS administrative database.  
First, the onset of T1DM mainly occurs in childhood or puberty.  We were able to obtain the 
ages of patients seeking UPMC services for the first time between 2001 and 2009, instead of the 
ages at diagnosis of DM or other complications.  Also, the present dataset includes age data only 
for 65% of patients.  We may be able to identify more probable and possible cases when more 
complete age data become available.  Second, factors that are helpful to determine whether 
patients have T1DM are the presence of islet antibodies, low c-peptide, episode of DKA, and 
other genetic and environmental factors.  Unfortunately, these events are rarely described in the 
office or hospital charts of patients with DM.  Third, T1DM patients depend on insulin 
permanently and critically.  However, medication data of insulin and/or OHA use were only 
available for inpatients.  We cannot depend on inpatient insulin use as the only judgment to 
distinguish T1DM from T2DM cases because diabetic patients are more likely to use insulin 
when they are hospitalized, and some patients may only use insulin temporarily after surgery or 
during hospitalizations.  Fourth, we used an adult cohort (age of 18 years or more) in the MARS 
database.  Our results have limited generalizability to children.  Fifth, there were some missing 
laboratory data if samples were sent to non-UPMC laboratories that do not supply data to MARS 
Another limitation to this study is that incomplete ascertainment of diabetic cases and 
types of diabetic cases.  It is likely some of the 80,145 patients who had only single indicator and 
did not meet Zgibor’s criteria6 may have true DM.  We used medico-administrative data to 
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identify the cases.  This may underestimate the real cases because most people with T2DM 
remain asymptomatic for years after onset of the disease, and only patients who received health 
care services are entered in these databases.  These are two possible conditions that could result 
in non-detection of potential cases of diabetes during the study period: (1) people with T2DM 
who did not need the services or treated exclusively with diet and exercise that were not on 
diabetic medications; (2) diabetic patients who use services for other reasons.  We may also have 
some misclassifications between T1DM and T2DM.  Some patients cannot be clearly classified 
as T1DM or T2DM.  Clinical presentation and disease progression vary considerably in both 
types of diabetes.  Occasionally, patients who otherwise have T2DM may present with 
ketoacidosis.  Similarly, patients with T1DM may have a late onset and slow, but virulent 
progression of disease despite having features of autoimmune disease.  Such difficulties in 
diagnosis may occur in children, adolescents, and adults.  The true diagnosis may become 
obvious overtime.  We have no independent source or “gold standard” such as surveys or 
diagnostic testing to quantify the cases we might be missing.   Even though the default tree in the 
probable cases selected the duration of MARS as a predictor, this factor may not be a good 
predictor generalizing to other administrative databases.  Lastly, we did not ascertaining the 
accuracy of our predictive rule through any internal or external validations in the current thesis.  
Due to all these inheriting limitations in an administrative database, our goal was to determine a 
set of criteria as an accurate and valid predictive rule to distinguish T1DM from T2DM instead 
of depending on a single indicator.   The predictors were developed for use that aim to support 
rather than replace the clinical judgment.    
Planning, implementing, monitoring, temporal evolution and prognosis differ between 
patients with T1DM and T2DM.  Accurate information about the magnitude, distribution, and 
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types of diabetes can inform policy, support health care evaluation and clinical prognosis in 
public health.   Our preliminary predictive rule to distinguish between T1DM and T2DM cases in 
a large administrative database appears to be promising and needs to be validated.  The public 
health significance is that being able to distinguish between these diabetes subtypes will allow 
future subtype-specific analyses of cost, morbidity, and mortality.  This study allows researchers 
to easily identify segments of a population that are more or less likely to exhibit the outcomes.  
We will not only be able to track different processes and costs of diabetes care delivery and 
progressions of clinical outcomes, but also will be able to identify characteristics that are 
important barriers to or facilitators of the health-related behavior of interest among T1DM and 
T2DM cases.   Future work will focus on ascertaining the validity and generalizability of our 
predictive rule, by conducting a review of medical charts (as an internal validation) and applying 
the rule to another MARS dataset or other administrative databases (as external validations).  
Then, we can further modify the preliminary rule to increase the numbers of T1DM and T2DM 
cases captured.  This ultimately will facilitate subtype specific analysis on processes and 
outcomes of patients with T1DM and T2DM.  
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APPENDIX A: PROGRAMMING DETAILS 
A.1 RPART LIBRARY AND ITS FUNCTIONS 
The basic steps to use RPART are addressed as follow. 
1) To use RPART, the users will have to load and attach the RPART package into S-Plus using 
the “library()” function.   
library(rpart)   
2) Decide what type of endpoint you have.  The rpart system was designed to be easily 
extended to new types of responses, including “anova”, “poisson”, “class”, or “exp”.  If the 
method argument is missing, an appropriate type is intelligently inferred from the response 
variable in the formula.  We only described “class” and “anova” in more detail here. 
• Categorical→ method = ‘class’.  A classification tree, with a categorical response and 
default impurity criterion the Gini index, selected by the argument parms = list 
(split=”information”).  The pruning criterion R(T) is the predicted loss, normally the 
error rate. 
• Continuous→ method = ‘anova’.  A regression tree, with the impurity criterion the 
reduction in sum of squares on creating a binary split of the data at that node.  The 
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criterion R(T) used for pruning is the mean square error of the predictions of the tree on 
the current dataset (that is, the residual mean square).  
• Poisson process or count→ method = ‘poisson’ 
• Survival→ method = ‘exp’ 
3) Fit the model using the standard S-Plus language.  The general usage of rpart is  
“fit <─ rpart(formula, data, weights, subset, na.action = na.rpart, method, model = false, 
x =  false, y = true, parms, control, cost,….)”.  
The default action deletes all observations for which y is missing, but keeps those in which 
one or more predictors are missing. 
4) Print a text version of the tree. 
print(fit)       #fit is the name of the tree 
5) Print a summary which examines each node in depth. 
summary(fit) 
6) Plot a standard version of the plot with some basic function. 
plot(fit) 
text(fit, use.n = TRUE) 
7) Create a prettier version of the tree. 
post(fit, file = ‘’) 
 
The rpart that both grows a tree and computes the optimal pruning for all α; although 
there is a function prune.rpart, it merely further prunes the tree at points already determined by 
the call to rpart, which has itself done some pruning.   It is also possible to print a pruned tree by 
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giving a pruning parameter to print.rpart.  By default rpart runs a 10-fold cross-validation and 
the results are stored in the rpart object to allow the user to choose the degree of pruning at a 
later stage.  The default behavior of rpart is to find surrogate splits during tree construction, and 
use them if missing values are found during prediction.  This can be changed by the option 
usesurrogate = 0 to stop cases as soon as a missing attribute is encountered.  A further choice is 
what do to if all surrogates are missing: option usesurrogate =1 stops whereas usesurrogate = 2 
(the default) send the case in the majority direction.   Function predict.tree allows a choice of 
case-splitting or stopping (the default) governed by the logical split. 
A.2 PROGRAMMING CODES FOR MARS DATA 
A. Probable Cases  
• Load RPART library: library (rpart) 
• Fit the tree model 
mars.rp <- rpart(DM~ sex+ race2 + Age + ICD.DMtype+insulin + oralagent + inpt+ 
outpt + er + DKA + Hypo.Coma + CVE +dialysis+ retinopathy + neuropathy + 
amputation + thyroid + celiac + addison+dur.MARS+ Age.CVE+ Age.neuropathy + 
Age.retinopathy+ Age.dialysis+ Age.amputation + Age.complication + count.cofactor + 
count.complication , data = mars.031010.dm12.probable, method='class') 
• A Plot and summary of default tree model (using proportional distance by the 
importance of the splits) 
89 
 
print(mars.rp);  
plot(mars.rp); text(mars.rp, use.n=T, pretty=0) 
title('A Tree-Based model for MARS Probable DM cases: RPART function') 
• A summary and plot of complexity parameter through cross-validations 
plotcp(mars.rp); title('Complexity Parameter vs Size of Tree') 
printcp(mars.rp) 
• Fit the pruned tree according to the complexity parameter 
mars.rp1 <- prune(mars.rp, cp=0.013) 
plot(mars.rp1); text(mars.rp1, use.n=T, pretty=0)  
title('A Pruned Tree Model for MARS Probable Cases-RPART function') 
print(mars.rp1) 
B. Possible Cases 
• Load RPART library: library (rpart) 
• Fit the tree model 
mars.rp.possible <- rpart(DM~ sex+ race2 + Age + ICD.DMtype+insulin + oralagent + 
inpt+ outpt + er + DKA + Hypo.Coma + CVE +dialysis+ retinopathy + neuropathy + 
amputation + thyroid + celiac + addison+dur.MARS+ Age.CVE+ Age.neuropathy + 
Age.retinopathy+ Age.dialysis+ Age.amputation + Age.complication + count.cofactor + 
count.complication , data = mars.031010.dm12.possible, method='class') 
• A Plot and summary of default tree model (using proportional distance by the 
importance of the splits) 
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print(mars.rp.possible);  
plot(mars.rp.possible); text(mars.rp.possible, use.n=T, pretty=0) 
title('A Tree-Based model for MARS Possible DM cases: RPART function') 
• A summary and plot of complexity parameter through cross-validations 
plotcp(mars.rp.possible); title('Complexity Parameter vs Size of Tree') 
printcp(mars.rp. possible) 
• Fit the pruned tree according to the complexity parameter 
mars.rp.possible1 <- prune(mars.rp.possible, cp=0.010) 
plot(mars.rp.possible1); text(mars.rp.possible1, use.n=T, pretty=0)  
title('A Pruned Tree Model for MARS Possible Cases-RPART function') 
print(mars.rp.possible1) 
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